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Abstract
2 
 
Objective 
A randomized clinical trial seeking evidence as to whether cardioplegic arrest (CA) or 
intermittent cross-clamp fibrillation (ICCF) method of myocardial protection technique 
would have any effect on the post-operative neuropsychological outcome in patients 
undergoing elective coronary artery bypass grafting (CABG) surgery.  
Methods 
One hundred and ninety-five patients were randomized to either CA or ICCF as the method 
of myocardial protection technique. Cerebral microemboli (ME) during surgery were 
recorded by transcranial Doppler monitor over the right middle cerebral artery. Evidence of 
cerebral impairment was obtained by comparing the patients’ performance in a 
neuropsychological test battery (9 tests) administered 6-8 weeks post-operatively with their 
pre-operative scores. 
Results 
The groups proved well balanced in pre-operative variables. During cardiopulmonary bypass 
(CPB) the median number and range of microemboli was 110 (1-1306) in the CA group 
compared to 105 (9-1757) for the ICCF group (p<0.567). One hundred and seventy-seven 
patients completed all the neuropsychological tests. The difference between the two groups 
did not reach significance (p=0.326, 2 tailed t test). 
Conclusion 
 
Given the similarity of effect in CA and ICCF techniques on the generation of ME and 
neuropsychological outcomes during CABG surgery, this investigation suggests that other 
than the myocardial protection technique analysed, there are other multiple causes that need 
to be studied. 
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An intraoperative assessment of the ascending aorta: a comparison of digital 
palpation, transesophageal echocardiography, and epiaortic ultrasonography 
207. 
 
Suvarna S, Smith A, Stygall J, Kolvecar S, Walesby R, Harrison M, Newman S. 
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Abstract 
 
OBJECTIVES: 
There are a number of techniques available to assess the aorta for atheromatous disease in the 
intraoperative period. This study compared the relationship among the findings of digital 
palpation (DP), transesophageal echocardiography (TEE), and epiaortic ultrasound (EAU) in the 
detection of atheroma in the ascending aorta. 
DESIGN: 
A prospective, observational study. 
SETTING: 
A single-institution, cardiothoracic specialty hospital. Participants: One hundred fifty-four patients 
undergoing elective cardiac surgery. 
INTERVENTIONS: 
The ascending aorta of patients undergoing elective coronary artery bypass surgery was 
assessed for atheroma by means of the 3 techniques. Atheroma was scored as present or 
absent. The sensitivity and specificity of the techniques were compared. 
MEASUREMENTS AND MAIN RESULTS: 
Assuming EAU provides the "gold standard," the sensitivity of both TEE and DP were low. Digital 
palpation identified only 20 patients (12%); TEE 31 patients (20%); and, in contrast, EAU 
detected atheroma in 81 patients (53%). There were 3 and 6 false-positives by DP and TEE, 
respectively. 
CONCLUSION: 
Assuming EAU as the "gold standard" to detect atheroma, this study has shown that when 
assessing the ascending aorta neither DP nor TEE appear sensitive. This study supports the 
proposal that detection of atheroma should be performed by EAU. 
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Abstract 
 
This study compared the occurrence of intraoperative microemboli and postoperative changes in 
neuropsychological performance in 195 patients undergoing coronary artery bypass grafting who 
were randomized to intermittent crossclamp fibrillation or cardioplegic arrest. Cerebral 
microemboli were recorded from cannulation to 15 min after decannulation, using transcranial 
Doppler in 166 patients. Microemboli in relation to 9 surgical events were also noted. 
Neuropsychological change scores were obtained by comparing cognitive performance 
preoperatively with that at 6-8 weeks after surgery. The median number of microemboli detected 
was 105 (range, 9-1,757) in the fibrillation group, and 110 (range, 1-1,306) in the cardioplegia 
group, with no significant difference between groups. There was also no significant difference 
between groups in the generation of microemboli during any of the surgical events. 
Neuropsychological tests were completed postoperatively by 177 participants, with no significant 
differences in performance found between the 2 groups. Given the equivalence of the effect of 
intermittent crossclamp fibrillation and cardioplegic arrest on microemboli and neuropsychology, 
consideration of which form of myocardial protection to employ should perhaps focus more on 
which method affords most protect 
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Introduction 
 
 
Coronary artery bypass graft (CABG) surgery is one of the most commonly performed 
cardiac surgical procedures worldwide, intended to treat ischaemic heart disease and alleviate 
angina pectoris. Despite advances in surgical procedure, cerebral injury is still an important 
complication after CABG .The two main clinical manifestations range from stroke to a subtle 
decline in neuropsychological (NP) performance. Roach et al (1996) from a multicenter 
study classified these cerebral injuries into two types1; Type 1 injury includes stroke, 
transient ischaemic attack, and coma (incidence 1.5% to 5.2%) 2. Type 2 injuries are subtler 
and include impairment of neuropsychological (NP) deficit (incidence that varies from 20% 
to 80%) 3.  
 
Neuropsychological (NP) deficit is more common and is defined as an impairment involving 
any or all of concentration, memory, learning or the speed of mental and visuomotor 
response. These NP deficits can be classified as short- (immediately after surgery) and long-
term (1-5 years post surgery) NP deficits following CABG, but the pathophysiology of these 
changes remains incompletely understood. But with improvements in protection techniques 
the risk of adverse NP outcome has improved to about 20% and these incidence of deficits 
vary according to the different methods and timing of measurements used in each study4. The 
cause of early NP deficit tends most likely to be mutifactorial and may include from 
microemboli (ME), hypoperfusion, and other factors resulting during  surgery, while late 
deficits occuring 1 and 5 years after surgery tend to be secondary to cerebrovascular disease 
among CABG patients5. Following three studies 1) Selnes et al (2001)5, 2) Newman et al 
(2001)6, and 3) Stygall et al (2003)7 have shown that long term NP deficits are seen 
persisting as long as 5 years. These incidences vary with published accounts due to 
methodological issues, including the timing of testing.  
16 
 
 
Although various factors and mechanisms may contribute to these NP deficits during CABG 
surgery, cardiopulmonary bypass (CPB) is considered to be one of the most significant 
causes8. Despite these findings, some recent studies have shown that such NP deficits are 
also seen in patients where CPB is not used9. 
 
But, this thesis focuses mainly on the NP deficits caused by myocardial protection techniques 
such as cardioplegic arrest (CA) or intermittent cross-clamp fibrillation (ICCF) during 
CABG surgery. Apart from different myocardial protection techniques NP deficits are also 
known to occur due to surgical handling of the ascending aorta leading to the release of 
microemboli (ME) from atherosclerotic plaques present in the ascending aorta10. Also, in this 
chapter we will look into various aetiological factors to see if they have some influence on 
post-operative NP outcomes especially during CABG surgery using the standard CPB 
technique comparing the two myocardial protection techniques. It is only since cardiac 
surgery became an extremely common and safer procedure10  in the 1970s that attention was 
able to shift from mortality rates to more subtle measures of outcome such as 
neuropsychological (NP) function.  
 
 However, the relationship between NP deficit and ME are still not clear with some finding a 
relationship 11,12,13 and others none14,15. With the possible incidence of atherosclerotic disease 
being present in this sub-group of patients undergoing CABG the identification of these sites 
and severity of atheroma in the ascending aorta during the intra-operative period is now 
hypothised as an important prologue in minimizing the incidence of adverse cerebral and NP 
events in the intra-operative period. 
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Therefore, in this thesis I have included the screening of the ascending aorta along with the 
detection through the transcranial Doppler (TCD) ultrasonography, of ME, which may occur 
during the CPB, comparing the two different myocardial protection techniques using CA and 
ICCF techniques. This chapter will also describe the development of NP testing, explain how 
it is best carried out, summarise the main findings relating to cardiac surgery and discuss 
some of the complex methodological issues involved. 
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Chapter 1  
 
Various factors that may influence the 
neuropsychological outcome after coronary 
artery bypass graft surgery    
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1.Various factors that may influence the Neuropsychological outcome after Coronary 
Artery Bypass Graft surgery  
 
1.1. Coronary Artery Bypass Graft surgery 
 
 
With over one million patients undergoing Coronary artery bypass graft surgery (CABG) 
annually, the incidences of cerebral injuries especially the occurrence of neuropsychological 
(NP) deficits would also tend to rise. A correlation between the severeity of coronary artery 
disease and the extent of atherosclerosis in the brain is increasingly becoming a common 
finding. Elderly patients over the age of 70 years are likely to have vascular disease of the 
cerebral circulation and therefore maybe more susceptible to microembolic injury than the 
younger patients.But, despite recent advances in surgical and anaesthetic techniques, causes 
leading to NP deficits are thought to be multifactorial and the pathophysiology of these changes 
are still not understood fully. Evidence is now emerging, however, that neurosychological test 
variables, patient-related factors and procedural related variables might have a more important 
role in post operative neuropsychological decline than previously thought.  
 
1.2.   Methods of Neuropsychological Testing 
 
In a clinical setting a psychologist would conduct the standard clinical NP assessment of an 
individual patient over one or two test periods totalling between about two and five hours. The 
patient is given a comprehensive battery of up to 25 standardised tests with the aim of 
identifying and localising a brain lesion, assessing the degree of cognitive disturbance in 
patients with known brain lesions or in order to distinguish between neurological and 
psychiatric symptoms16. The NP assessment of outcome following cardiac surgery differs from 
this standard assessment in several ways.  
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Firstly, assessments must be performed both prior to and then following surgery, rather than the 
single assessment thus enabling comparisons to be made between the patients own baseline 
score pre-operatively to post-operative performance.   The purpose is to measure change in 
performance over time.  Time constraints only allow about one hour for each of the pre-
operative and post-operative tests. Therefore, in order to perform as many tests as possible and 
so be as comprehensive as possible in testing different cognitive domains, relatively short tests 
must be selected. Investigators have used between 1 and 14 tests in various studies. The fact 
that the test will be repeated shortly afterwards demands that the test should have a minimal 
learning effect.  Parallel forms of the same test may be used to reduce learning effects.  If the 
tests were too easily learnt this would decrease the sensitivity of post-operative testing.  Some 
degree of learning is inevitable with most tests and it is expected that the majority of patients 
without impairment will show an improvement in neuropsychological test performance post-
operatively. As learning is inevitable, it is best taken into account using Z change scores 
(discussed in later chapter).  It can therefore be seen that the battery of tests one uses to assess 
patients before and after cardiac surgery is a compromise between wishing to be as 
comprehensive as possible while completing testing in about one hour. 
 
Previous incidence studies were designed to assess what affect cardiac surgery had on 
cognitive function. These previous early studies used a single group assessed on at least two 
separate occasions. This work established that a proportion of patients do show a post-operative 
neuropsychological decline but the incidence varied widely.  While it has been suggested that 
such a variety of results could be due to an inherent problem of neuropsychological testing, the 
variability is no greater than that reported for post-operative strokes17– a related problem which 
is often perceived as a more reliable outcome measure as it has overt clinical signs and 
consequences. It is worth considering the reasons for variability between results of these 
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incidence studies. The factors that will affect results are test, patient, study design and data 
analysis variables. 
 
1.2.1. Neuropsychological Test Variables 
 
As has already been mentioned, neuropsychological testing in cardiac surgery is a compromise 
between being exhaustive in assessing cognition and being able to perform the tests in the 
limited time available. The more tests that are used, the greater will be the probability of 
detecting a lesion because more domains are being tested.  However the potential problem of 
using too many tests is that some may test the same domain and result in a deficit appearing 
worse than it actually is.  The sensitivity of the tests used in neuropsychology test batteries has 
improved as the study of NP outcome has been refined.  The early studies used intelligence 
tests or tests such as the Mini Mental State Exam.  Although these are highly reliable they are 
relatively insensitive18 and a number of tests have now been specifically chosen for use in 
cardiac surgery as per the Statement of Consensus recommendation19. This core battery 
minimally includes the Rey Auditory Verbal Learning Task, the Trail Making Tests A and B, 
and the Grooved Pegboard. These tests are now widely used, easy to conduct, well-normalised, 
and sensitive to cerebral damage.  
 
The way in which tests are administered is highly important but it is rarely mentioned in 
publications.  To ensure reliability of assessments it is preferable that the same psychologist 
does the pre-surgery and post surgery tests in the same environment. Factors such as noise and 
lighting may have effects upon test results. Also it is important that the patient can practise 
tests and so be fully aware of what is expected with each test and perform to the best of his/her 
ability.  
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1.2.2. Neuropsychological Stastical Analysis variables 
 
The statistical analysis of NP data may have a significant influence on the incidence of 
neuropsychological deficit found.  Methods of analysis have evolved in an effort to be more 
sensitive but there is no universally accepted method.  Some investigators have been criticised 
for using as many methods as possible to analyse their results and then presenting the method 
which yields the most significant result. It is therefore important to define the type of analysis 
to be used when designing a trial and deciding on sample numbers. One has to choose a method 
of analysis to use before starting a trial and then keep to this plan. 
 
The earlier, descriptive studies, which involved a single group of patients undergoing cardiac 
surgery, examined NP change from before to after surgery.  The change in performance was 
analysed as group comparison or individual comparison.  Group comparison consists of 
pooling data and determining whether the group as a whole has altered its performance.  In 
order to detect a deficit the mean of the group has to drop significantly.  This makes the 
assumption that most patients will experience a deficit, but in fact only a minority of patients 
are likely to.  Also it takes no account of the potential learning effect of the tests.  The patients 
who improve through learning may mask the patients who deteriorate.  This type of analysis 
therefore has flaws.  Probably superior for single group studies are individual comparisons 
which examine individual changes with each patient acting as his own control.  The main 
problem that then arises is how to define what extent of neuropsychological deterioration 
constitutes a deficit.  There is still no consensus as to what constitutes a deficit.  However most 
researchers accept that deterioration on at least two tests is required as a poor performance on 
only one test may simply reflect a lapse in performance. (Although it may also mean that only 
one cognitive domain has been affected). A deficit has usually been defined in standard 
deviation (SD) terms with most investigators classifying a deficit as a drop in one or more SDs 
from the pre- operative to post-operative levels.  The SD may be a population SD when 
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standardised tests are used or it may be calculated from the pre-operative performance in an 
attempt to establish a notional standard score for the group being examined.  However this 
method may become insensitive because it applies a fixed amount of deterioration to all 
individuals regardless of their absolute levels.  Another similar approach is to take a drop in 
20% in a test performance to reflect a significant deterioration. This therefore overcomes the 
problem by taking a proportional drop in performance to define a deficit. 
 
When interventional studies are analysed, there are again a number of approaches.  In these 
studies, there are two or more groups having cardiac surgery with or without a particular 
intervention. There are now several ways in which group comparisons can be performed in 
interventional studies. One alternative method, the individual incidence approach, used by 
Pugsley20, and described by Newman21  enables a comparison to be made between the groups 
in terms of the number of individuals showing a deficit. A standard deviation (SD) unit is first 
calculated from all the patients’ preoperative scores. One then calculates the change in score for 
each patient for each test.  In an identical manner to the methods of descriptive studies, a deficit 
in a test is said to occur when the patient’s individual score in a test decreases by more than one 
SD from their preoperative score.  A patient has a significant deficit if this occurs in 2 or more 
tests.  One then compares the incidence of deficits between two or more groups. This 
conventional definition was widely applied in research until a few years ago when some 
drawbacks became apparent.  In addition to the problem of arbitrarily defining a deficit, as 
explained above, it also has also become less sensitive.  This method classifies a patient in a 
binary fashion as either having a deficit or not having a deficit with no intervening scale. 
Sensitivity is therefore reduced when analysing by incidence of deficits. As the incidence of 
NP deficits has declined with improvements in surgical and perfusion and anaesthesia practice, 
the lack of sensitivity has become more apparent.  Another criticism of the incidence of deficits 
method is the phenomenon of “regression towards the mean”.  Regression towards the mean is 
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the statistical observation of a biological phenomenon whereby extreme baseline scores tend to 
become less extreme on repeated testing.  In the case of NP testing before and after cardiac 
surgery it has been argued that those with higher preoperative scores are more likely to regress 
towards the mean and show an apparent, although not real, deterioration.  Conversely, those 
with low scores preoperatively would improve in a similarly spurious way if they regressed 
towards the mean.  However this theoretical argument can be refuted by the facts observed 
after cardiac surgery which are the exact opposite: those patients with better preoperative NP 
scores tend to deteriorate less22. 
 
More recently Arrowsmith et al14, 23, 24, 25 have introduced “Z”, or “change” scores and these are 
now becoming an additional accepted way of analysing NP data with greater sensitivity. To 
calculate a Z score each patients’ test score on each occasion is converted into a standardised 
score by dividing by the SD of the preoperative group performance of all patients in a study. A 
change score is then calculated for each patient by subtracting the postoperative standardised 
score from the preoperative standardised score.  One can then calculate a mean of the change 
scores for each group. This method is more sensitive because it is a continuous change score 
without absolute cut offs.  It also allows group comparisons which take into account potential 
learning affects. Since Z scores have only recently been introduced, it is a more sensible 
approach to analyse NP results using deficit scores as well as Z scores.  This has the advantage 
of making it possible to compare incidence of deficits to previous studies. 
 
 
1.3 Patient-related varaibles 
 
 
There are a number of patient-related variables that could explain the differences.  
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1.3.1. Age 
 
The age group of patients undergoing CABG surgery in the United Kingdom has been 
increasing steadily over the past decade as per the National Adult Cardiac Surgical Data base 
report 2011-201226. At present nearly a quarter of all patients are above the age of 70 years and 
out of that 8% are over the age of 75 years. There is considerable evidence that age is 
associated with NP outcome following CABG surgery. Older patients have a worse 
outcome21,27,28,29. 
 
This may be due to more ME release in older patients30 or the fact that with the increase in the 
mean age, the cerebral blood flow auto regulation on CPB may be impaired in these sub-groups 
of elderly patients21. This will be further discussed in this chapter as well as subsequent 
chapters. 
 
        1.3.2. Gender 
 
Overall more male patients undergo CABG surgery when compared to women. But there is 
some evidence that women are at higher risk than men for NP deficits after cardiac operations, 
perhaps because more have pre-existing hypertension than men. A study by Hogue et al31 
assessed 117 patients (79 men and 38 women) undergoing cardiac surgery using a battery of 
neurological tests including a broad array of cognitive domains including attention, memory, 
executive function and psychomotor processing speed. The tests were conducted a day 
before the operation and 4 to 6 weeks post-surgery. Although the frequency of NP outcome 
was similar between women and men, women appeared to be more likely to suffer injury to 
brain areas sub-serving visuo-spatial processing. The same author in randomized study 
found no difference in NP outcomes using 17beta-estradiol in postmenopausal women
229
.  
 
26 
 
1.3.3. Left ventricular dysfunction 
 
Left ventricular (LV) dysfunction is known to be associated with increased operative and 
post-operative mortality in patients undergoing CABG surgery. It might, therefore, be 
expected that there may be an association between poor left ventricular function and poor 
post-operative NP outcomes because of post-operative low cardiac output status. Depressed 
LV function may thus lead to intra-operative haemodynamic instability and low-output 
state directly disturbing normal cerebral perfusion and contributing to neurological events. 
Blachly and colleague in 1966 showed that post-operative neurological symptoms such as 
confusion and hallucinations were related to low post-operative cardiac output
32
. Poor LV 
function has been named as one of the predictors of causing early NP deficits in a more 
recent study
33
. 
 
1.3.4. Pre-existing cerebrovascular disease 
 
Harrison et al in 1989
34
 investigated the relationship between pre-existing cerebrovascular 
disease and NP dysfunction. A series of 78 patients undergoing CABG surgery were 
studied
 
prospectively to see if angiographic evidence of cerebrovascular disease
 
demonstrates any correlation with the incidence of NP dysfunction at 8 days or
 
8 weeks 
after surgery. Out of 78 patients, only 47 had complete angiography and NP assessment. In 
51% there was evidence
 
of vessel wall disease and in 17% there was stenosis of at least one 
carotid artery
 
in the neck, of which only one patient had severe narrowing. In total, 77%
 
of 
these 47 patients showed an NP deficit as defined by a
 
significantly reduced score in at 
least 2 of 10 tests administered at 8 days
 
after surgery. At 8 weeks post-surgery, 36% still 
had deficit. Their study did not show any significant correlation between angiographic 
evidence of carotid artery disease and the development of NP deficit. They conclude from 
their results that NP deficits are common with or without carotid artery disease, with or 
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without frequent episodes of hypotension and with or without evidence of pre-existing 
cerebrovascular insult. This implies that cerebrovascular disease is not a major factor in the 
development of post-operative NP deficit. However, this study was underpowered with 
only a small number of patients having severe carotid disease while transcranial vessels 
were not examined. 
 
1.3.5. Hypertension 
Hypertension is a major risk factor for coronary artery disease and cerebral injuries. 
Hypertension is usually associated with impaired cerebral blood flow regulation to the 
brain and when in the presence of other co-factors such as age and diabetes mellitus, 
peripheral vascular disease can cause damage to the brain, heart, kidney and other major 
organs in the body. Therefore, the relationship between hypertension and NP deficits has 
been the topic of interest for many decades.  
 
Cross-sectional, population based studies have had mixed findings regarding hypertension 
and cognitive outcome. Some studies by Farmer et al, 1985 and Scherr et al, 1991 have 
found minimal or no relationship
35,36
, whereas Elias et al in 2003 found an association with 
higher blood pressure
37
 and Guo et al, 1997 noted an association with lower blood 
pressure
38
. 
Longitudinal studies including the Framingham heart study and the Etude du Vieillissement 
Artériel (EVA) study indicate that NP performance persists or worsens over time among 
hypertensive patients
39,40,41
. 
1.3.6. Obesity 
The relationship between obesity and vascular disease is well known. It plays an important 
role along with hypertension, diabetes and hypercholesterolemia in increasing the overall 
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risk factors for any neurological injuries. Eighteen-year surveillance data collected from the 
Framingham heart study by Elias and co-workers, 2003 showed obesity and hypertension 
to have adverse effects on the cognitive outcomes in the general population
37
. 
 
1.3.7. Diabetes mellitus 
The mechanisms of post-operative NP deficit in patients with diabetes following CABG 
surgery are not fully understood
225
. 
 
Miles and Root in 1922 conducted an NP study because of complaints of memory loss and 
difficulty in concentrating in diabetic patients. They compared diabetic and non-diabetic 
patients. Their work suggested that diabetic patients might experience a significantly 
greater impact on cognitive function
42
.  
 
The human brain is almost totally dependent on a continuous supply of glucose, 
deprivation of which rapidly causes malfunction. In the brain there are regional differences 
in the susceptibility to neuro-glycopenia with the cerebral cortex being most sensitive while 
deeper structures are more resistant. Repeated episodes of hypoglycaemia do lead to 
cognitive impairment
43
. There is little information whether iatrogenic hypoglycaemia plays 
a role in post-operative disturbances of cognition. Notzold et al, 2006 studied n=34 patients 
(n=14 diabetics, n=20 non-diabetics) undergoing CABG surgery. Pre-operatively tests 
examined the emotional NP state, stress-coping ability and quality of life. Emotional and 
NP tests were assessed daily from day 2 to 5 post-operatively. They found that in the 
diabetic group the post-operative NP outcomes were significantly longer (Stroop test 
P=0.02, the Abbreviated Mental test P=0.02 and the Trail Making test P=0.04) compared to 
non-diabetic patients
44
.
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Kadoi et al, 2005 studied 180 type II diabetic patients undergoing first-time CABG surgery 
to determine what type of type II diabetes related factors contribute to post-operative NP 
deficit. They matched the age, sex and educational level of these patients against 100 
patients without diabetes as a control group. All patients underwent a battery of neurologic 
and neurological assessment the day before, 7 days and 6 months post-surgery. There was 
significant NP deficit at 7 days and 6 months after surgery related to insulin therapy, the 
presence of diabetic retinopathy and the level of haemoglobulin A 1c in the type II diabetic 
patients
45
. Therefore, in insulin-dependent diabetes mellitus it is unclear whether these 
patients are more at risk of NP deficits but there is evidence that the way in which serum 
glucose is managed on bypass can affect the NP outcome
46
. 
 
1.3.8. Peripheral vascular disease 
 
Ancona et al in 2003 retrospectively analysed 9,916 patients from January 1999 to June 
2002 who had undergone CABG surgery, out of which 280 patients had peri-operative 
stroke (2.1%). Univariate analysis identified peripheral vascular disease (PVD) as one of 
the determinants of neurological incidence
47
. Subsequently, the severity of PVD is also an 
independent risk factor of NP outcome (Phillips, Mate-Kole, 1997)
48
.  
 
Shaw et al, 1987 examined NP function in 312 patients before and after CABG surgery. 
Fifty patients with PVD undergoing surgery were used as a surgical control group and 20 
non-surgical patients as a control group. Out of the 50 patients with PVD, 9 (18%) 
developed neurological complications resulting from trauma to lower limb sensory nerves. 
Two of the 50 developed primitive reflexes. Fifteen of 48 (31%) showed NP deficit
49
.  
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1.3.9. Genetic 
 
The association of apolipoprotein E (APOE) and NP dysfunction is well established in 
Alzheimer’s disease. The gene coding for APOE occurs as three common alleles 2, 3 and 
4. APOE proteins are responsible for the repair of neuronal injuries that would make 
patients more susceptible for NP dysfunction in the post-operative period. Tardiff and co-
workers’ preliminary report of a genetic basis for NP deficit following CABG surgery in 65 
patients in 1997, suggested that APOE genotype is related to cognitive decline
50
. This led 
to STOEd and co-workers in 2001 from London, England, re-examining  Tardiff and 
colleagues’ earlier work by increasing the sample size to 111 patients who were undergoing 
CABG. Their investigation and a recent study by Silbert et al suggested that the 4 allele 
was not associated with NP deficit
51,233
. There is a need for a more wide-ranging 
investigation of genetic markers in an attempt to explain individual patient vulnerability in 
this context.  
 
1.3.10. Educational level, socio-economic status and mood 
 
Interestingly, higher numbers of years of formal education is found to protect patients from 
NP deficit
21
. It is still unclear whether higher education increases the cognitive reserve in 
an individual, thereby improving their test-taking capability or enhances neuronal 
homeostasis making them more resistant to neurological insult. Ho et al 2004 studied 
CABG surgery patients to identify patient-related risk factors, process of care and the 
occurrence of any intra-operative complications associated with NP deficit following 
surgery. Nine hundred and thirty-nine patients undergoing CABG surgery at 14 veterans’ 
administration medical centres between 1992 and 1996 were enrolled into the Process, 
Structures and Outcomes of Care following surgery. They completed a short battery of 
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cognitive tests at baseline (72 hours prior to surgery) and 6 months post-surgery. 
Interestingly, they showed that more years of education were associated with less NP 
deficit (p=0.001)
52
. 
 
A study albeit involving only 22 patients undergoing CABG surgery by Folks and 
colleagues suggests that lower socio-economic status may confer greater risk for post-
operative NP morbidity
53
.  
 
It is also quite interesting to know whether pre-existing NP problems such as depression 
and altered mood status have any influence on the post-operative outcome following 
CABG surgery. McKhann and colleagues in 1997 assessed 124 patients using the Centre 
for Epidemiological Study OF Depression (CES-D) scale along with a series of NP tests. 
Patients with a CES-D score above 16 were defined as depressed. Only 12 (13%) of 
patients not depressed before surgery were depressed 1 month afterwards, whereas 18 
(53%) of those who were depressed before surgery were depressed at one month (p=0.001). 
At the one-year follow-up, 8 (9%) patients not depressed before surgery and 16 (47%) 
patients depressed prior to surgery were depressed (p=0.001)
54
. 
 
In 2001, Millar and colleagues studied 81 out of 120 patients who underwent CABG 
surgery. Their patients performed the Stroop Neuropsychological Screening Test and other 
psychometric assessment prior and 6 days and 6 months post-surgery. The presence of pre-
surgery depression was found to be a significant predictor of post-operative state at 6 days 
follow-up (p<0.001). At 6 months there was no late onset impairment: No patient was 
impaired without having previous impairment
55
. 
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1.4. Surgery/Procedure-related variables 
 
1.4.1. Cardiopulmonary bypass  
 
Cardiac surgery involving CPB has undergone many changes since its introduction starting 
with the bubble to the membrane oxygenator CPB machine. Padayachee et al in 1987 
studied 27 patients who underwent CPB surgery (bubble n=17, membrane n=10). They 
showed membrane oxygenators to produce fewer ME as detected by TCD when compared 
to a bubble oxygenator
56
. Subsequently, the study by Smith et al 1990 compared these two 
oxygenators to detect any relationship between cerebral microembolisation and NP 
outcome. They found membrane oxygenators to cause less NP deficits
57
.  A randomized 
controlled trial of 103 patients by Scott et al in 2002 found no difference in early (5 day) 
NP outcome with roller or centrifugal bypass pumps
58
. 
 
1.4.2. Duration of Cardiopulmonary bypass  
 
Several studies over the years have shown that NP deficits were found to increase with a 
prolonged duration following CPB
59,60,61
 while some did not confirm this effect (Hammeke 
1988)
62
. Brown et al described a post mortem examination of brain specimens obtained 
from 36 patients who died within 3 weeks after CPB
63
. Specimens were embedded in 
celloidin and stained with endogenous alkaline phoshatase. This outlined the arterioles and 
capillaries. In such preparations emboli could be seen as swellings in these vessels. 
Cerebral ME were then counted as small, medium or large in order to estimate the overall 
emboli load. They found thousands of ME in these specimens soon after CPB. They 
concluded that the longer duration of the bypass was associated with a significantly 
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increased embolic load (P=0.0026). An interesting finding was that as time increased 
following the bypass, the percentage of large and medium emboli decreased (P=0.0034), 
thereby suggesting that emboli break into smaller globules with time as they pass through 
the capillary network.  
 
It is also important to note that numerous factors and circumstances may contribute to 
prolong the duration of CPB time. Technical problems or complications during surgery 
along with difficulty in weaning the patient off CPB are the main causes of prolonged 
bypass. With an ever-increasing group of high-risk patients undergoing CABG surgery, 
from the foregoing discussion it is clear that all these factors may contribute to a higher risk 
of neurological and NP outcomes. 
 
1.4.3. Inflammatory response to CPB 
 
CPB is associated with an interaction between blood and foreign surfaces producing a 
"whole body inflammatory response”. This produces a systemic inflammatory reaction 
(SIR) that can often lead to dysfunction of major organs especially the renal and pulmonary 
system. Leucocytes in particular neurophils, once activated are thought to interact with 
blood components and the vascular endothelium to produce tissue injury and possibly ME. 
These inflammatory processes have been suspected to cause NP deficits
64,65,235,236
. 
However, their effects on the cerebral system are less well understood. Despite this, there 
have been conflicting findings regarding the impact of the inflammatory process on post-
operative NP outcome.  
 
Increased blood concentrations of the glial protein S100β have been measured after 
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operations using CPB and in some studies have appeared to be associated with neurological 
complications. However, this protein is not only restricted to brain tissue, but is also found 
in peripheral nerves, extracts of fat, bone marrow and organs of mesenchymal origin
66,67
  . 
The blood levels of inflammatory mediators were found to be significantly raised in shed 
mediastinal blood obtained by cardiotomy suction during and after surgery
68
. The half life 
of S100β is approximately 25 minutes and therefore its presence in the circulation 24 hours 
following cardiac surgery has been used as a useful marker of late mortality by Johnnson et 
al
69. Rises in S100β   have also been seen in non-cardiac surgical patients following spinal 
surgery
70
.  
 
A study using S100β by Georgiadis et al, in 2000 assessed 190 consecutive patients 
undergoing elective cardiac operations for CABG surgery (n=147), valve surgery (n=29), 
or both (n=14). This and the 1999 study of Kilminster et al involving 130 cardiac patients 
having pre and post-operative neurological assessment showed a correlation between   
increased levels of S100β early after the operation and neurological complications71,72. 
Several factors have been implicated in the initiation of an inflammatory response. The 
factors include exposure of blood to foreign surfaces, ischaemic-reperfusion of organs, 
surgical manipulations, non-pulsatile flow and endotoxin release. These in turn activate the 
complement, coagulation, fibrinolysis and kallikrein-kinin pathways leading to leucocyte 
activation. 
 
 
Because of the complement mediated brain cell injuries that occur following the exposure 
of blood to the foreign surfaces of the cardiopulmonary bypass circuit, Baufreton et al in 
2004 randomly assigned 30 patients undergoing coronary surgery to either a standard non-
35 
 
coated or heparin-coated (to decrease possible complement activation) bypass circuit in 
order to evaluate the role of complement activation on cellular cerebral injury. NP 
assessment tests were conducted 2 week prior and at the time of discharge while sC5b-9 
levels tested complement activation. The sC5b-9 levels were found to be significantly 
higher in the non-coated group at the end of CPB (p=0.005). Glial injury was measured 
using s100β levels at different times before, during and after CPB. At the end of CPB, the 
levels were significantly higher in the non-coated group than in the coated group (p=0.008). 
Higher levels were still seen in the non-coated group 4 hours after initiation of CPB 
(p=0.02). When they compared the correlation between inflammation, atheroma and 
cerebral injury, the incidence of aortic atherosclerosis did not differ significantly between 
the two groups. However, s100β levels at the end of the CPB were found to be higher in the 
patients who had severe ascending aortic atheroma when compared to those with intimal 
thickening (p=0.018)
73
. 
 
Westaby et al, 2001 in a prospective study involving 100 first-time CABG surgery patients 
sought evidence of any relationship between NP deficit and systemic inflammatory 
response following CPB. Inflammatory markers (complement release products C4a, 
terminal complement complex C5b-9, Interleukin-6) and markers of coagulation and 
fibrinolysis (platelet degranulation-β- thromboglobulin, thromboxane B2, prothrombin 
activation-F1+2, D-dimer) were analysed at several time points during and after the 
operation. A battery of NP tests was used a day prior and at 5 days and 3 months post-
surgery. Out of the 95 patients who satisfactorily completed the pre-operative assessment, 
only 79 patients completed the 5-day post-operative assessment. Two patients were 
excluded because of stroke and the remaining 14 declined the time consuming examination 
at that time. However, at the 3-month post-operative period, 89 patients were able to 
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complete all the tests. Their study was unable to detect any significant correlations between 
the inflammatory markers and NP outcomes at 5 day and 3 months post-surgery
74
. 
 
In summary, due to the lack of a reliable and specific marker of brain inflammation that 
could be used after CPB, the role of systemic inflammatory response in neurological injury 
following cardiac surgery is still open for debate. Various strategies have been used to 
reduce inflammatory phenomena in patients undergoing CPB. Blood collected from the 
surgical field is filtered and washed prior to reinfusion. Although widely accepted in 
cardiothoracic literature, this strategy has never been formally evaluated in any large-scale 
study. The emergence and expanding performance of cardiac surgical procedures without 
the use of CPB has given us an excellent tool to investigate the relative importance of CPB 
as a cause of systemic inflammation.  
 
1.4.4. Perfusion: Pressure, flow, arterial filter and pulsation 
 
Global hypoperfusion of the brain has been implicated as an important factor in the 
aetiology of NP deficits during cardiac surgery
75
. In recent years there has been much 
debate regarding the perfusion pressure needed during CPB to maintain adequate cerebral 
blood flow. Mean arterial pressure (MAP) is the major factor affecting cerebral perfusion 
pressure (CPP). Cerebral blood flow (CBF) is maintained at a relatively constant level by 
auto regulation over a wide range of perfusion pressure (50-150mmHg). Perfusion pressure 
below 50mmHg is associated with a fall in CBF, subjecting an individual to potential 
cerebral ischaemia. The parieto-occipital cortex, which lies at the boundary supplied by all 
three cerebral arteries is the most vulnerable watershed areas
76
. 
 
There is, however, some evidence that hypoperfusion can be a significant contributory 
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factor in cardiac surgery relating to ischaemic cerebral injury. Tufo et al who studied 100 
patients undergoing CABG in 1970 found that the incidence of post-operative neurological 
insults was higher (78 vs 27%) in those with a mean perfusion pressure of 40mmHg 
compared to 60mmHg
72
. But in a later study, Gold et al (1995) investigated the use of 
higher pressures by prospectively studying cardiac and neurological outcome in 248 
patients undergoing elective CABG in two groups with lower (50-60 mmHg) or higher (80-
100mmHg) pressures. Six months after surgery the overall incidence of cardiac and 
cerebral complications was significantly lower in the higher pressure group (4.8% Vs 
12.9%,p=0.026), as was the stroke rate (2.4% Vs 7.2%) but their study failed to show any 
NP differences between the groups
78
, while some showed improvement with higher 
pressure
228
. 
 
However, Caplan et al suggested that cerebral blood flow may have a significant effect on 
NP and neurological outcomes via effects on ME. This study hypothesised that the effect of 
emboli was worse when the perfusion pressure to the brain was less because there is less 
“washout” of emboli. However, the study failed to show any direct evidence to support 
this
79
. Theoretically, a higher cerebral flow rather than pressure could deliver more 
microemboli to the brain. 
 
Although various arterial filters have been used, they are still not being used universally. At 
present they are popular, especially in the United States of America, due to their ability to 
remove microemboli and also larger air emboli in the event of a perfusion accident
80
. A 
recent study by Whitaker et al using leucocyte depleting arterial filter during CABG 
showed that by reducing the number of ME release, the overall NP outcome was better
81
. 
 
38 
 
With regard to pulsatile vs non-pulsatile flow, various studies have shown different patterns 
to perfusion and NP outcomes. Murkin and colleagues in a prospective double-blinded 
randomised study of 316 patients undergoing CABG in 1995 were not able to show any 
changes
82
. 
 
1.4.5. Temperature 
 
The main question between temperature management during CPB and subsequent NP 
outcome has been debated along temperature at which CPB is conducted and the rate at 
which rewarming is achieved. Hypothermia has been used as a cardioprotective and 
neuroprotective strategy throughout the development of cardiac surgery. The following 
studies have investigated the effects of normothermic compared to hypothermic bypass on 
cerebral and NP outcomes with conflicting results. 
 
Grigore and colleagues
83
 2001 at the Duke Heart Cente investigated a prospective 
randomized trial of normothermic vs hypothermic CPB on NP outcome after CABG. Out 
of 300 patients, 149 were in the normothermic group (35.5-36.5C) and 151 in the 
hypothermic group (28-30C). In the final analysis of the 227 patients who took part in the 
6-week NP follow-up, hypothermic CPB did not provide any additional protection to the 
brain when compared to normothermic CPB. 
 
Rewarming after hypothermia is theoretically a potential cause for cerebral and NP 
dysfunction due to enhanced cerebral metabolism. Grigore et al, in a recent randomized 
study using slow or more rapid rewarming of patients from hypothermia found that the NP 
outcomes were better among the slow rewarming group at 6 weeks post-surgery
84
.
 
It has 
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also been suggested that rapid rewarming may produce ME from the anaesthetic gases.   
Nathan et al examined the effects of two different rewarming methods at the end of CPB. 
In their randomised study all patients were cooled to 32˚C during CPB and then rewarmed 
to either 34˚C or 37˚C with no further rewarming. They used a battery of 11 NP tests and 
found incidences of 62% and 48% deficit at 1 week post-surgery in patients randomly 
allocated to normothermia or hypothermia at the time of rewarming on CPB, even though 
their findings suggested that the 34˚C group had a less NP deficit at 1 week and 3 months 
post-operatively. At 3 months, the difference was seen in only 1 of the 11 tests, suggesting 
that the difference between the groups at 1 week was a temporary effect, which disappeared 
by three months
85
. The same investigators in their 5-year follow-up of the study in 2007 
reported that patients who had greater neuro cognitive decline at 1 week after surgery 
showed poorer performance 5 years later. They also found that the magnitude of cognitive 
decline over 5 years was modest and the incidence of deficits was not different between 
temperature groups. Finally, only a few patients in the hypothermic group had deficits that 
persisted over the 5 years, with no statistical significance (RR=0.64, P=. 16). They 
concluded that even though there was evidence of a neuroprotective effect of mild 
hypothermia early after surgery in the original cohort, the results after 5 years were 
inconclusive, warranting further studies
86
. 
 
In summary, even though hypothermia is neuroprotective it may be the very process of 
rewarming to normothermia and above that is harmful. The effects of the rate and extent of 
rewarming on cerebral outcome have not been studied but their potential effect must be 
remembered if hypothermia is used.  
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1.4.6. Acid-base management 
 
As temperature decreases, the solubility of carbon dioxide (CO2) in blood increases. Thus 
during hypothermic CPB as the temperature drops, the partial pressure of CO2 (pCO2) 
decreases. Arterial blood gases when analysed during hypothermia would give a picture of 
respiratory alkalosis (decreased PaCO2 and increased pH). Acid-base can be managed by 
two methods ‘pH-stat’ involving the addition of CO2 to normalise the PaCO2 and maintain 
a pH of 7.40 or ‘alpha-stat’ involving blood gases being measured at 37C regardless of 
body temperature.  
 
There is evidence that alpha-stat management leads to a better cerebral and NP outcome. 
 
Bashein and colleagues in 1990 reported that there were no influences using pH stat or 
alpha stat management
87
.  But Stephan and colleagues in a randomized study involving 65 
patients showed a higher incidence of NP deficits using pH-stat management
88
. This was 
also supported by Murkin et al in a randomized study involving 316 patients where alpha-
stat managed patients had less NP deficits especially in patients who were subjected to 
more than 90 minutes of CPB
82
. Other studies have also reported similar findings
89,90
. 
 
Patel et al in 1996 randomized 70 patients to either pH-stat or alpha-stat control and both 
the groups were cooled to 28˚C. Their study showed a NP deficit in the pH-stat group at 6 
weeks post-surgery. They also detected an increase in cerebral blood flow velocity along 
with hyperaemia especially in the pH-stat group. Their study suggests that since pH stat 
management disturbs the normal auto regulatory mechanism of cerebral blood flow there is 
an increased association of diffuse cerebral insult
89
. It has been suggested that an increase 
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in flow leads to an increase in the number of ME delivered to the brain.This has been 
suggested from animal model studies that a reduction in temperature or an increase in 
PaCO2 levels can lead to increased cerebral blood flow along with an increased number of 
ME being delivered to the brain
91
. But Patel in his study did not measure ME
89
.  
 
1.5. Atheromatous disease in the ascending aorta 
 
From previous studies of CABG surgery patients, it is apparent that over 50% of patients 
who present for cardiac surgery have evidence of either extracranial or intracranial 
atherosclerotic disease
92
. With the increase in the mean age of patients undergoing 
coronary artery surgery, the incidence of aortic atheromatous disease has also gone up 
steadily. Some studies suggest that CPB and manipulation of the aorta are the two most 
likely sources of poor NP outcome during conventional CABG
93
 and because of this, there 
is a close relationship with any cerebral embolic event occurring during surgery
94,95,96,97
.  
 
A later chapter looking into the detection of atheromatous disease in the ascending aota 
using various screening techniques like Digital palpation (DP), Transoesophageal 
echocardiography (TOE) and Epiaortic ultrasonography (EAU) will discuss its close 
relation to ME and its impact on NP outcome. 
 
1.6. Microembolism 
 
 Cardiopulmonary bypass increases the permeability of the blood –brain barrier230 and 
generates microemboli (ME), which may effect the NP outcome.A number of investigators 
maintain that the atheroma of patients is the most significant of the ME sources and that 
atheromatous ME are detrimental to the NP outcome
98, 99,100
.  But when all studies are 
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considered it seems that ME are multifactorial with many sources.  The fact that ME are 
detectable in children having surgery to correct congenital cardiac defects suggests that 
non-atheromatous sources are also important in the production of ME
101
. 
 
We will discuss in detail in a later chapter how ME could be identified “live” using TCD 
during CABG surgery and investigate whether there is a co-relation to the NP outcome. 
 
1.7. Myocardial protection techniques 
 
Since the mid 1970’s Cardioplegic arrest (CA) has been the most widely practised 
technique for myocardial protection. Nevertheless, intermittent cross-clamp fibrillation 
(ICCF) has continued to be preferred by a minority of surgeons in both high and low-risk 
patients
102
. Various studies have shown ICCF to be a safe or safer strategy than CA for the 
heart through preconditioning
10,103,104,105,106,107
. Exponents for ICCF claim that the 
technique is simpler, allowing the myocardium to be reperfused during the procedure, and 
has the potential to result in shorter ischaemic and CPB) times
103
. 
 
However, ICCF is known to be associated with more handling and repeated clamping of 
the aorta.  It has been argued that in the presence of atheromatous disease, this 
manipulation may cause plaque adhering to the aortic wall to crack or rupture releasing 
debris (microemboli) into the systemic circulation and that a proportion of these ME could 
eventually find their way into the cerebral circulation
108,109
. The surgical manoeuvres 
identified as being most likely to cause this disruption are aortic cannulation/decannulation, 
cross-clamp application/removal and construction of proximal anastomises
11,99
.
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Despite various studies comparing the effectiveness of the myocardial protection benefits, 
unfortunately there is only one small study that has compared the post-operative generation 
of ME and NP outcomes in patients undergoing either ICCF or CA during CABG 
surgery
10
. 
 
Subsequent chapters will study in detail some of the variables to see if there is a possible 
association between NP outcome and ME generation during CPB using ICCF or CA as the 
myocardial protection techniques.  
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Chapter 2  
 
Role of atheromatous disease in the ascending 
aorta in neuropsychological outcome during 
cardiopulmonary bypass  
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2. Role of atheromatous disease in the ascending aorta in neuropsychological outcome 
during cardiopulmonary bypass  
 
2.1. Introduction 
 
The natural history of atheromatous disease is a slowly progressive systemic inflammatory 
process of the arterial system with plaque formation associated with intimal thickening that 
takes place over several decades starting from childhood. The usual morphological features 
include cellular proliferation, lipid accumulation, inflammation, necrosis, fibrosis and 
calcification. Ulceration of these plaques may result in embolisation, which can lead to NP 
deficits, stroke and death. These findings have been validated following clinical trials and 
post-mortem findings
109,110
. 
 
Recent investigators have been able to demonstrate that the incidences of cerebral 
(stroke,TIA and NP deficits) complications were significantly higher in patients who had 
been shown to have a higher atherosclerotic burden in the brain, carotid arteries and the 
ascending aorta
111
.  
 
CABG involves manipulation of the ascending aorta by arterial cannulation, cross-
clamping and side-clamping, all of which can increase the risk of embolisation of 
atherosclerotic material to the brain. This along with other co-factors such as advancing age 
of patients have all been implicated in causing NP complications following CABG surgery 
due to the presence of atherosclerotic lesions in the ascending aorta.  
 
This chapter will review the literature to further elucidate the various screening techniques 
available to detect atheroma and examine whether there is any relationship between 
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atherosclerosis of the ascending aorta and NP outcome after CABG surgery due to the 
handling of the ascending aorta during surgery using the conventional CPB machine. 
 
2.2. Incidence with associated co-morbid factors 
 
The presence of atherosclerosis in the ascending aorta is an important risk factor for 
cerebral embolisation leading to stroke and associated NP problems during CABG surgery. 
Although an association between atherosclerosis of the aorta and peripheral embolism has 
been speculated over the years, the importance of the ascending aorta as a source of 
cerebral and vascular emboli has only recently been established. Blauth et al provided 
evidence for the role of aortic atheroemboli. Their study of 221 post-mortems established 
that atheroemboli were more common after coronary revascularisation than after valvular 
procedures (p=0.008). Peripheral vascular disease and ascending aortic atherosclerosis 
were significant independent risk factors for atheroemboli. Atheroembolic events occurred 
in 46 of 123 patients (37.4%) with severe disease of the ascending aorta but in only 2 of 98 
patients (2%) without significant ascending aortic disease (p < 0.0001). Forty-six of 48 
patients (95.8%) who had evidence of atheroemboli had severe atherosclerosis of the 
ascending aorta. Their study showed a direct correlation between age, severe 
atherosclerosis of the ascending aorta, and atheroemboli
112
.  
 
Davila-Roman et al 1991 relied on EAU to detect atherosclerosis in high-risk patients. An 
analysis of pre-operative variables revealed that age and diabetes were the only significant 
independent predictors of severe atherosclerosis identified by EAUof the ascending 
aorta
113
. 
 
Davila-Roman et al 1999 in a prospective study involving a cohort of 1,957 consecutive 
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patients evaluated their ascending aortas with EAU at the time of cardiac surgery starting 
from January 1990 to May
114
.
 
The cardiac surgical procedures performed included: CABG 
surgery in 1,472 (75.2%), valve repair or replacement in 224 (11.5%) and combined valve 
and CABG surgery in 261 (13.3%). Of the 1,957 patients who underwent follow-up 1,147 
(58.6%) had a normal ascending aorta, 461 (23.5%) mild atherosclerosis, 250 (12.8 %) 
moderate atherosclerosis and 99 (5.1%) severe atherosclerosis of the ascending aorta. A 
total of 491 events occurred in 472 patients (Ccerebral events 92, all-cause mortality 399). 
They showed a statistically significant association between hypertension (p=0.009), 
atherosclerosis of the ascending aorta (p=0.011) and diabetes mellitus (p=0.015). The 
independent predictors of mortality were advanced age (p<0.0001), left ventricular 
dysfunction (p<0.0001), ascending aorta atherosclerosis (p<0.0001), hypertension 
(p=0.0001) and diabetes mellitus (p=0.0002). There was >1.5-fold increase in the incidence 
of both cerebral events and mortality as the severity of atherosclerosis increased from 
normal-mild to moderate and a greater than 3-fold increase in the incidence of both as the 
severity of atherosclerosis increased from normal-mild to severe. Their prospective study 
was the first to show that atherosclerosis of the ascending aorta is an independent predictor 
of long-term mortality. They were also able to show that in patients with severe 
atherosclerosis of the ascending aorta there was a three-fold increase in cerebral and all-
cause mortality rate when compared with patients with a normal ascending aorta. 
 
The Schachner et al
115
 study examined 500 patients undergoing coronary surgery between 
1998 and 2003 to determine factors that would predict the presence of atherosclerotic wall 
thickness in the ascending aorta. Maximum ascending aortic wall thickness significantly 
correlated with age (p<0.001), pre-operative creatine level (p=0.004), European system for 
cardiac operative risk evaluation (EuroScore, p< 0.001), and maximum descending aortic 
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wall thickness (p<0.001).  
 
 
Van der Linden et al
116
 prospectively studied 921 consecutive patients undergoing elective 
cardiac surgery to evaluate the risk of calcified atheroma in the ascending aorta and the 
extent and topography of the disease in the development of stroke after cardiac surgery. 
The presence of calcification, location of atheroma, extent of the disease and clinical 
variables such as stroke were recorded. The ascending arch and descending aorta was 
screened using DP, TOE and EAU. A total of 26.2% of the patients had atheroma in the 
ascending aorta. Logistic regression showed that atherosclerotic disease in the ascending 
aorta was the most predictive factor for post-operative stroke. The incidence of stroke was 
1.8% in patients without atherosclerotic disease and 8.7% (p<0.0001) in patients with the 
disease in the ascending aorta. Diabetes mellitus was also a predictive factor (p=0.04). An 
interesting finding of this study was that the middle-lateral segment was an independent 
predictive factor for post-operative stroke, with a relative risk of 26% (p=0.04). 
 
A direct correlation between age and ascending aortic atherosclerosis was also found. 
Approximately 20% of patients 50 years of age or over undergoing cardiac surgery have 
atherosclerotic disease in the ascending aorta
115
. 
 
Kapetanakis et al in a risk-adjusted study involving 7,272 patients undergoing CABG 
surgery showed that the incidence of post-operative cerebral injury increases with aortic 
manipulation
108
. Therefore, detection of atheroma in the ascending aorta prior to 
manipulation during coronary artery surgery is considered to reduce the overall incidence 
of neurological injury and NP dysfunction, especially in elderly patients
115,117
.  
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Also several other investigators such as Blauth 1992
112
, Roach 1996
64
, and Hogue 1999
118
 
have all suggested a correlation between the presence of atherosclerosis in the ascending 
aorta and post-operative neurological events. Therefore, it seems evident that 
atherosclerosis of the ascending aorta must be identified during the intra-operative period 
to minimize the risk of a cerebral atheroembolic event
119
.  
 
Theoretically, aortic cannulation, clamping, manipulation and de-cannulation could all lead 
to the release of atheromatous material from the ascending aorta and cause cerebral 
vascular accidents (CVAs). Identifying the sites and severity of atheroma in the ascending 
aorta intra-operatively is now postulated as an important prelude to minimize the incidence 
of adverse cerebral events in the intra-operative period. 
 
 
2.3. Different screening techniques 
 
 
 
An ordinary chest X-ray for the pre-operative identification of atherosclerosis of the 
ascending aorta visualizes only the large calcified areas and thus underestimates the 
frequency of atherosclerosis
120
.  
 
In this chapter we will investigate three techniques that are commonly used intra-
operatively to assess atheroma in the ascending aorta: 
 Digital palpation (DP) 
 Transoesophageal echocardiography (TOE) 
 Epiaortic ultrasonography (EAU) 
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We shall also investigate which imaging technique might be the so-called “Gold Standard” 
in identifying atheroma. 
 
2.3.1. Digital palpation  
 
Digital palpation (DP) has historically been the primary method of detecting atherosclerosis 
in the ascending aorta during surgery. It is a simple method commonly used by surgeons to 
directly assess the aorta by feeling for any abnormality and grading them according to the 
consistency felt. DP has also been very widely studied but with evenly unimpressive 
results. Ohteki et al 1990
121
 in a prospective study assessed 100 patients with coronary 
disease using DP and compared the results against transoesophageal and computed 
tomography. They found that DP detected only 25% of the atherosclerotic plaques that 
were detected echocardiographically, while both DP and computed tomography undervalue 
the frequency of detection of atheroma compared to EAU. Another study by Sylviris et al 
1997
122
 (n=100 patients undergoing coronary or valve surgery) found that DP 
underestimated the severity of atheroma in the ascending aorta when compared against 
ultrasound imaging techniques in up to 69% of the patients. 
 
 
2.3.2. Transoesophageal echocardiography  
 
 
The American Society of Echocardiography (ASE) established the Council for Intra-
operative Echocardiography in 1993 and 1997; the council board created a set of 
guidelines
123
.  
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Although the use of Trasnoesophageal echocardiography (TOE) to detect atheroma has 
been standard practice in CABG surgery, there are problems in visualizing the mid and 
distal portions of the ascending aorta with this technique as the trachea lies between the 
oesophagus and the distal ascending and proximal aortic arch. These regions are difficult to 
image and cannot be assessed reliably. This is an important segment of the ascending aorta 
since aortic cannulation and application of the aortic cross-clamp is usually placed in the 
distal segment of the ascending aorta. Therefore, Konstadt and co-workers
124
 in 1994 used 
TOE to see how far it can be used to image the ascending aorta. They examined 27 patients 
undergoing cardiac surgery. The ascending aorta was directly measured independently by 
the surgeon starting from the annulus to the origin of the innominate artery [length of 8.9 
+/- 1.3cm (mean +/- SD)] and to the level of the aortic cannulation site. These 
measurements were compared against TOE (7.4 +/- 1.1cm) measurements. Both TOE and 
EAU were also used to assess the aorta for any atheroma. The range of the difference 
between the two measurements was 0.2-4.5cm. The aortic cannula was seen only in 1 of 27 
patients and severe atherosclerotic plaques (>3mm thick) not seen on TOE were detected in 
5 patients with EAU. As much as 42% (4.5cm of 10.7cm) of the length of the ascending 
aorta was not visualized and potentially embolic plaques were not imaged by TOE. These 
findings suggest that TOE may have limited use in the pre-cannulation assessment of the 
aorta for plaque and the detection of distal ascending aortic pathology. 
 
The same author in 1995
125
 examined the entire thoracic aorta to predict the presence of 
plaque in the ascending aorta in n=81 patients. Using EAU as the "gold standard", the 
sensitivity, specificity, positive predictive value, and negative predictive value of TOE for 
detecting ascending aortic atherosclerosis were calculated. Using epiaortic ultrasound four 
(17%) of the 81 patients had significant atherosclerotic disease of the ascending aorta. The 
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sensitivity of TOE was 100%, the specificity 60%, the positive predictive value 34% and 
the negative predictive value 100%. These data show that if the complete biplane TOE 
examination is negative for plaque then it is highly unlikely that there is significant plaque 
in the ascending aorta. If the TOE examination is positive for plaque then there is a 34% 
chance that there is significant disease of the ascending aorta and an EAU should be 
considered. Other studies by Marshall 1989
126
 and Davila-Roman 1996
127
 had also shown 
that TOE significantly underestimates the severity of ascending aortic atherosclerosis, 
particularly in the distal ascending aorta. 
 
 This has led investigators to use EAU that is able to directly image the proximal, mid and 
distal portions of the ascending aorta
127,128,129
.  
 
 
2.3.3. Epiaortic ultrasonography  
 
Intra-operative assessment using epiaortic ultrasonography (EAU) is a technique that was 
introduced by Marshall et al
126
 for patients undergoing cardiac surgery. Using EAU, 
atherosclerosis was diagnosed by this method in 58% of a selected series of patients 
wherein the surgical technique had to be changed in 24% of patients overall because of its 
findings. Several investigators have confirmed EAU to be superior to TOE and DP for 
assessing the ascending aorta (Konstadt 1994
124
, Davila-Roman 1996
127
, Syliviris 1997
122
, 
Roysce 1998
130
, Wilson 2000
109
, and Bolotin 2005
128
). 
 
Most often atherosclerotic disease can be identified in 20-25% of the patients, especially in 
the distal segments of the ascending aorta using EAU (van der Linden 2001
118
, Davila-
Roman 1994
113
 and Marshall 1989
126
). 
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Although the details of the ascending aorta can easily be obtained there are still doubts 
whether topographic pathology can have an impact on the incidence of post-operative 
neurological deficits. There is one study by van der Linden et al
116
 which showed that if the 
ascending aorta was divided into 12 segments i.e. three transverse and four longitudinal, 
then the distal anterior segment tends to be more affected than any other segment. 
 
However, EAU has been claimed to reduce the incidence of intra-operative stroke by 
leading to changes in surgical techniques by detecting diseased segments of aorta as shown 
by Wareing et all in1992
119
.  
 
2.4. Location and grading of atheroma 
 
Understanding the distribution pattern of the atheroma along the ascending aorta is 
important so that by identifying the exact location of the atheroma, the surgeon can 
determine what portion of the aorta should be avoided during surgical procedure. 
 
Tobler and Edwards
131
 studied the frequency and location of atherosclerotic plaques in the 
ascending aorta. Ninety-seven adult specimens with coronary disease were examined. The 
right side of the ascending aorta was more commonly involved than the left. The sites least 
commonly involved were the right posterior, upper-right anterior and lower posterior 
locations. In specimens with plaques at the orifice of the innominate artery, nearly 80% had 
plaques in the ascending aorta and 73% of specimens with plaques at the orifice of the left 
subclavian artery had plaques in the ascending aorta. 
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Atherosclerosis of the aorta has been graded by several ways using ultrasonography of 
intimal thickening (Wareing et al 1993
119
, Ribakov et al 1993
132
 and N. Trehan et al 
2000
133
) (Table2. 1).  
 
Table 2.1 
Grading of aortic atheroma   (Adopted by Trehan et al) 
 
Initial case studies in the US classified intimal thickening of 5mm and above as significant 
atheroma 
134 
(Table 2.2).  
 
Table 2.2   
Adopted by Tunick et al 
<1mm OR=1.0 
1-3.9mm OR=3.9 
>4mm OR=13.8 
 
Intimal thickness in mm, OR= Odds ratio 
 
However, subsequent studies by the French Aortic Plaque in Stroke (FAPS) group by 
Amarenco et al
129
 in 1994 evaluated 500 patients over the age of 60 years. They concluded 
that the increase in odds ratio (OR) for an embolic event was as follows: The intimal 
Grade 1 Plaque less than 5mm into the aortic lumen 
Grade 2 Plaque more than 5mm into the aortic lumen 
Grade 3 Plaque with a mobile element 
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thickness<1mm OR=1.0 (no increased risk); for 1 to 3.9mm OR=3.9; and for plaques 
>4mm OR=13.8 (Table2.2). It must be noted that they qualified that this risk may have also 
been associated with the presence of carotid stenoses. 
Table 2.3  
 
 
The French Aortic Plaque in Stroke (FAPS) group 
< 1mm No risk 
1 - 1.9mm  
Increases cerebrovascular events 
 
2 - 2.9mm 
3 – 3.9mm 
> 4mm Marked increase in cerebrovascular events 
 
Intimal thickness in mm 
 
 In a subsequent 1996 study the French Study of Aortic Plaque in Stroke (FAPS)
135
 group 
evaluated 331 patients and although they confirmed a markedly increased risk with plaques 
greater than 4mm, there was a significant increase in cerebrovascular events with plaques 
between 1 and 3.9mm.  Several other studies have also shown that the presence of severe 
atheroma is associated with higher incidence of cerebral injury
115,117,136
. 
 
Davila-Roman et al
137
 divided the ascending aorta into three equal segments between the 
aortic annulus to the innominate artery. They graded atheroma as mild atherosclerosis if 
intimal thickening (<3mm) involved only 1 segment of the ascending aorta, as moderate if 
intimal thickening (>3mm) involved 1 or 2 segments and severe if intimal thickening 
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(>3mm) involved all three segments or occurred circumferentially around the aorta 
(Table2. 4). 
 
Table 2.4 
Grading of atheroma    Davila-Roman et al
 
Score Description  Definition 
0 No atheroma No atheroma 
1 Mild atherosclerosis Intimal thickening <3mm 
2 Moderate atherosclerosis Intimal thickening >3mm 
3 Severe atherosclerosis Circumferential thickening>3mm or 
pedunculated Plaque 
 
Intimal thickness in mm 
Grading was also important in predicting the incidence of intra-operative stroke in a study 
by Mizuno & colleagues. This study of 315 consecutive patients undergoing CABG 
surgery found that when the aortic arch intima was >5mm, patients were at significantly 
greater risk of intra-operative stroke
138
. 
 
 
     2.5. Gold standard imaging technique 
 
 
While it is inevitable that any imaging technique will have both false positives and 
negatives, EAU currently seems to offer the best sensitivity and specificity of all the intra-
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operative techniques. Although EAU has become the gold standard for detecting 
atherosclerotic changes in the ascending aorta it can only be used to detect atheroma during 
the intra-operative period. If the findings do not reflect the anticipated diagnosis then a 
decision regarding technique has to be made during surgery. However, it would be better if 
such decisions could be made pre-operatively. Hence to support the “gold standard” 
assumption one should also determine whether other imaging techniques such as CT scan 
could evaluate severe atherosclerosis in the ascending aorta as effectively as intra-operative 
EAU. Bergman et al screened 20 consecutive patients for atherosclerotic disease in the 
ascending aorta undergoing elective coronary surgery and compared pre-operative CT with 
intra-operative EAU findings. AS EAU detected atherosclerosis in a significantly higher 
proportion of patients than CT, they concluded that CT scanning was inferior to today’s 
gold standard method of EAU in detecting the extent and location of atheroma in the 
ascending aorta
139
. Finally, as indicated by Summers et al other non-invasive diagnostic 
techniques including MRI might also be of great value in the pre-operative evaluation of 
severe atherosclerosis in the ascending aorta
140
. 
 
 
2.5. Discussion 
 
In contrast to TOE and EAU, DP fails to identify significant plaques in the ascending aorta 
in 50-60% of the cases as shown by van der Linden 2001
116
 and Marshall 1989
126
. A 
second limitation is the lack of a uniform classification system for grading atherosclerosis 
of the ascending aorta as various investigators have used different cut-off values to define 
atheromatous lesions in the wall as pathologic: 0.5mm (van der Linden 2001
116
), 1.0mm 
(Amarenco 1994 
129 
and Sylivris 1997 
122
) and 3.0mm (Hangler 2003
141
, Lev-Ran 2005
142
, 
Davila-Roman 1999
100  
, and
 
Konstadt 1995
111
). Moreover, the number of grades used to 
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classify intimal thickening has varied, being expressed in two categories mild or 
severe
122,129
, three catogories mild, moderate or severe
114,136,141
 or even in four catogories 
mild, moderate, severe I and severe II
143
. 
 
 
2.6. Summary 
 
A correlation between the degree of coronary artery disease and the extent of 
atherosclerosis of the ascending aorta is becoming a common risk factor for stroke and NP 
deficit following coronary surgery. The level of risk depends on the presence, location and 
grade of the disease especially when the ascending aorta is surgically manipulated. Several 
studies discussed in this chapter suggest that intra-operative EAU use should be routine, so 
that surgical manipulation could be reduced or when possible avoided in patients with 
atherosclerosis of the ascending aorta. With this in mind we have used EAU for screening 
the ascending aorta along with the traditionally used TOE and DP method in this thesis, 
comparing ICCF with CA so as to minimize the possible incidence of and embolic event 
during CABG surgery. 
 
Since elderly patients with more advanced coronary artery disease are likely to have 
vascular disease of the cerebral circulation and might, therefore, be more susceptible to 
microembolic (ME) injury than the younger patients during coronary artery bypass grafting 
surgery. The next chapter we will look into this in detail. 
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Microemboli  
 
 
 
 
 
 
60 
 
3. Microemboli  
 
3.1. Introduction 
 
Microemboli (ME) are emboli that are less than 200µm in diameter
144
. The precise 
composition of these ME is not clear. They may be gaseous, particulate or lipid with further 
subdivisions into natural or inert material. Both gaseous and particulate materials cause 
obstruction of distal end-arterial flow in cerebral arteries, resulting in end-organ failure. In 
addition ME are thought to cause secondary to local inflammatory responses
145
.  
 
The generation of ME during CABG surgery has been implicated as a possible aetiological 
cause of cerebral injury. This section will describe their composition; explain the various 
means by which they can be detected especially using TCD and review literature to find 
any possible link or evidence that might support their involvement in causing NP 
dysfunction during CABG surgery. 
 
 
3.2. Gaseous Microemboli 
 
Air is one of several sources of gaseous ME that could possibly cause central nervous 
system injury. Anaesthetic gases are more commonly implicated in the production of 
ME
130
. Gaseous ME can also occur due to the CPB circuit or the surgical techniques used. 
There is evidence that cannulation of the aorta and right atrium can entrap air. Air has been 
shown to be entering the right atrium via the venous cannula if the purse string holding it is 
inadequate, especially since the right atrium is sub-atmospheric in pressure. Air or oxygen 
can enter via the bypass circuit. Bubble oxygenators that were used previously generated 
more ME than the present membrane oxygenator thereby reducing the incidence of NP 
outcome with this newer technique
146
. 
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It has been shown that during open heart surgery air commonly enters the left side of the 
heart and despite the best techniques used for de-airing, there will still be some “air 
bubbles” left behind147. Oka et al148 used TOE for the definition of the incidence and 
monitoring of the removal of retained air. They showed retained air in 2 of 18 (11%) of 
patients having CABG compared to 12 of 15 (79%) who underwent valve surgery. Trace or 
moderate amounts of air were still seen in the left atrium or aorta 1 to 5 minutes post-CPB. 
 
During the rewarming phase of the CPB, the partial pressure of gases would increase and 
tend to force them out of the solution and, therefore, there is an increased chance of 
bubbles being generated at this time. Rapid rewarming could thus have a damaging effect 
on NP function because of this but unfortunately there are no studies that examine the rate 
of rewarming and ME production.  
 
 
3.3. Particulate Microemboli 
 
The sources of particulate ME are numerous. They could be thrombin, fibrin, platelets, 
leucocytes, fat globules, atheroma, calcium and even denatured proteins. Studies have 
shown an increase in the number of ME during aortic cannulation and this is thought to be 
due to atheromatous or calcific debris rather than air.  
 
Several investigators have shown atheroma to be the most significant of ME sources 
causing an unfavourable NP outcome
99,149
. However, when these studies are analysed it 
seems that ME are heterogeneous in origin with many sources. ME generation in children 
undergoing congenital cardiac correction suggests that non-atheromatous sources are also 
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involved in their production
99,102,149
. 
 
Liu et al used a Coulter counter (an electronic particle-size analyser) and an electron 
microscope to quantify particulate ME during CPB in-vitro. Particules between 15 and 
80m in diameter were detected and viewed directly150. They found that the three sources 
of ME were transfused blood, the cardiotomy reservoir and the bubble oxygenator. Liu and 
co-workers showed that in the first hour of bypass there was a linear correlation between 
time of perfusion and blood destruction. The number of ME detected, steadily increased 
during the first hour and then ceased to change after that. Particulate ME may be generated 
by damaged blood elements and their subsequent aggregation. There was a 5-fold rise in 
the number of ME once the activated blood and lipid that were collected by the cardiotomy 
sucker passed through the reservoir. They also showed that the bubble oxygenator 
increased the number of ME generated by 2 to 3 times, when compared to a membrane 
oxygenator. Liu et al studies also seem to show that cardiotomy suction produced lipid ME, 
while examining cellular element. Kaza et al have found that patients randomized to have 
cardiotomy suction rather than a cell-saver suction device have greater lipid ME at the end 
of CPB
151
. 
 
 
 
 
3.4. Detection of Microemboli release following Cardiopulmonary bypass 
 
Many investigators have used a variety of methods to detect the ME generated and have 
focused on a number of different sites during cardiac surgery. The aorta, carotid artery, 
middle cerebral artery or even the retinal arteries have all been used to detect the ME. The 
methods can be direct or indirect. An early, indirect method was the “screen filtration 
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pressure” technique of Swank152 where the presence of micro aggregates in stored blood 
was measured by the pressure needed to push blood through a screen filter of a given pore 
size. Other indirect methods include the Coulter counter
153
 that measures micro particles of 
0.4 to 800m in diameter, again in-vitro. It has been criticised for measuring only at a 
single time point and not being able to measure gaseous ME or to continuously measure 
ME. 
 
Investigations looking for direct evidence of ME to the brain, occurring during bypass are 
based on: 
 Histological examinations 
 Retinal angiography 
 TCD 
 
3.4.1. Histological examination 
 
Moody et al
154 
and other workers have used histological means to examine the brains of 
animals and humans following cardiac surgery to study the evidence of ME. Moody was 
the first to report small capillary and arterial dilatations (SCADs) in the autopsy brains of 
patients post-cardiac surgery. Although SCADs are exclusively seen in cardiac patients 
their actual cause remains unknown. It is thought that these SCADs are the “footprint” left 
behind mainly due to lipid ME when the solvent, alkaline phoshatase staining technique 
used in preparing the sections of the brain, has removed the actual embolic material.  
 
 
3.4.2. Retinal angiography 
 
Investigators such as Blauth et al
153,155,156
 have used the retinal circulation as a visible 
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extension of the cerebral microvasculature. They used the photographic technique of retinal 
fluorescein angiography to demonstrate retinal microvascular occlusions consistent with 
retinal ME.  They also found that retinal microvascular occlusions were more common in 
patients with NP deficit. This is an invasive technique compared to TCD and it does not 
allow continuous monitoring for ME. Retinal fluorescein angiography can detect the effect 
of ME only at discrete time points. Although Blauth et al did develop a method to quantify 
the ME producing the occlusions, this technique did not gain popularity.  
 
3.4.3. Transcranial Doppler  
 
 
Transcranial Doppler (TCD) is the most commonly used non-invasive method for detecting 
ME in ‘real time’ and to investigate blood flow within the intracranial cerebral arteries. In 
order to obtain a TCD trace, the probe is placed against the skull above the zygomatic arch 
and the ultrasonic beam directed at the blood flow in the middle cerebral artery. In about 
10% of the people it has not been possible to isonate the middle cerebral artery through the 
temporal bone because of varying thickness of the bone. The acoustic properties of embolic 
material, gaseous or particulate, differ from blood so that the emboli reflect the ultrasound 
more strongly than blood, producing a distinct pitch. It is these pitch changes or an embolic 
signal defined as a short duration signal, with an intensity 10db greater than the background 
and associated with a characteristic ‘chirp’ that produce the audible sounds called “High 
Intensity Transient Signals” (HITS). In fact, it allows continuous “live” monitoring of ME 
along with blood flow velocity. Of the three main intracranial arteries, the middle and 
anterior cerebral arteries are the terminal arteries of the ipsilateral internal carotid artery. 
Wijman et al
157
 has shown that the middle cerebral artery is easier to isonate to detect HITS 
when compared to the anterior cerebral artery, being a bigger calibre vessel and the most 
accessible through the window of thinner bone in the temporal bone. The number of ME 
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detected is probably related to the proportion of cerebral blood flow within each artery.  
 
These HITS detected by TCD have been shown to correspond to ME made of air, platelets, 
fibrinogen or atheroma in laboratory in-vivo experiments
158,159
. Blauth et al disapprove of 
TCD since the number of HITS may not exactly reflect the number of emboli if automated 
counting is carried out. But the same criticism would apply to any other method mentioned 
earlier that does not have the same continuous “live” detection capability of ME that a TCD 
has. Therefore, in order to standardize the detection of ME, either gaseous or solid material, 
and make studies comparable, a number of recommendations for detection and recording 
have been made by the International Consensus Group (Ringelstein and associates in 
1998)
160
. 
 
Padayachee et al
56 
in 1987 were the first to use TCD during cardiac surgery. They detected 
embolic signals or HITS in 22 out of 27 patients at the time of aortic cannulation and in all 
patients during CPB using bubble oxygenators but none with membrane oxygenators. TCD 
as routinely used is able to detect both solid and gaseous ME, but cannot distinguish 
between the two. Since then, most investigators have continued to use TCD as the preferred 
method for detecting intra-operative ME despite its inability to differentiate between 
gaseous and particulate matter, even though recent researchers like Russel and Brucher
161 
have suggested that distinction may be possible. This distinction is necessary to investigate 
the pathological sequelae of differentiating emboli. Other issues such as uni or bilateral 
isonation of the middle cerebral artery have also been studied. The 2001 study of Moser 
and co-workers
162 
of unilateral verses bilateral monitoring of cerebral ME in 29 patients 
found only a 4% difference between sides and has shown that unilateral monitoring are 
sufficient when the goal is to characterize a given subject’s ME load. Therefore, the 
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number of ME detected by TCD may be related to the proportion of cerebral blood flow. 
 
A recent study by Markus et al
163
 used a novel Embo-Dop system, using insonation at 2-
ultrasound transducer frequencies system. They compared the gaseous embolic signals 
obtained in 7 patients with known patent foramen ovale by intravenous injection of agitated 
saline injections, with solid embolic signals that were obtained in patients with 
symptomatic carotid stenosis (N=23). The Embo-Dop dual-frequency system suggested 
better discrimination than a simple intensity threshold but it was found not accurate enough 
for use in clinical or research studies. They, therefore, suggested further work was required 
in order to develop reliable clinical systems for discrimination of emboli. The clinical 
importance of the distinction lies in the probability that the 2 types of emboli have different 
pathological effects. 
 
 
 
3.5. Timing and generation of ME -- variables 
 
3.5.1. Perfusionist 
 
The perfusionist has been shown to play a part in the release of ME by Taylor and 
colleagues 1999
164
. The CPB circuit consisted of a soft shell venous reservoir, a hollow-
fibre membrane oxygenator and a 32-micron arterial filter. The mean embolic rate was 
calculated for three time periods: 1) during surgical interventions (aortic cannulation and 
decannulation, cross-clamp application and removal, at initiation and end of CPB and start 
of cardiac ejection); 2) during perfusionist interventions (blood sampling and drug 
administration into the venous reservoir) and; 3) during baseline (all other time periods 
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during CPB). The number of emboli per minute was significantly higher (p<0.001) during 
perfusionist interventions (6.9+/-4.5) than during surgical interventions (1.5+/-1.5) or 
during baseline (0.4+/-0.5). It was suggested that drug administration resulted in a higher 
embolic rate than blood sampling and these emboli were likely to be air bubbles that are 
not eliminated by the arterial line filter. Borger et al
165
, in a 2002 study have also confirmed 
this. 
 
3.5.2. Surgical manipulations 
 
 
Surgical techniques can vary from surgeon to surgeon and also from one institution to 
another. This may also play a role in the release of embolisation during different aspects of 
the surgical procedure during CABG. Several studies by Barbut and co-workers 
demonstrated that nearly 60% of all emboli happened during clamp manipulation of the 
ascending aorta and following the release of cross-clamp
99,166,167
.  
Numerous events during surgery may also be associated with the timing of the ME: 
 
 Chest opening 
 Purse-string application prior to aortic cannulation -- full thickness bite 
 Aortic cannulation 
 Start and end of CPB 
 During CPB, longer bypass time 
 Cross-clamping of aorta 
 Cardioplegia delivery, cannulation at root 
 Lifting of the heart, during distal anastomosis 
 Single/multiple partial aortic clamp, during top-end anastomosis 
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 Decannulation of aortic cannulae 
 
Embolisation primarily takes place as a result of aortic manipulation during palpation, 
cannulation, cross-clamping, proximal coronary anastomosis and decannulation and 
possibly secondary to ‘sand blast’ effect from high-velocity jet existing from the aortic 
cannulae. 
 
Barbut et al
99
 in 1994 studied 20 patients undergoing CABG. They noticed that embolic 
signals were detected in all patients, but in 34% microembolic signals were detected as 
aortic cross-clamps were removed and in 24% when aortic partial occlusion clamps were 
removed. Only 5% were detected at the initiation of the bypass. Rates for embolisation 
were 15.15 embolic signals per minute at cross-clamp removal, 10.9 embolic signals per 
minute at partial occlusion clamp removal and fewer than 3 embolic signals per minute at 
other times. Correlation was found between the number of emboli and severity of aortic 
atheroma and NP deterioration. They suggested from the study that ME were associated 
with aortic cross-clamp release. 
 
Other studies by Aranki
168 
(1994) and Bertolini
169
 (1997) have pointed out that partial 
occlusive clamping of aorta might act as a source of atheroembolic release leading to 
neurological dysfunction. 
 
Baker et al
170
 1995 studied patients, comparing release of ME in three different blood 
cardioplegia techniques; cold antegrade (n=20), warm antegrade (n=17) or warm retrograde 
(n=20) cardioplegia. Continuous monitoring was divided into stages: Aortic cannulation, 
initiation of CPB, aortic cross-clamping, aortic declamping and decannulation until chest 
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closure. The embolic events ranged from 22 to 2,072 per patient and were similar among 
groups. The rate and total at each stage were also similar. Total embolic events were 
highest during aortic clamping while the rate was highest at the initiation of the bypass. ME 
events were higher in the warm retrograde group than both antegrade groups during aortic 
declamping. 
 
Benaroia et al
171 
1998 prospectively studied 32 first-time CABG patients. They analysed 
the number of ME in the middle cerebral artery (MCA) during CPB to see if it correlated 
with the blood velocity or the direction of flow as determined by the shape and size of the 
aortic cannula. Three aortic cannula types were used: 24F curved (n=19), 24F straight (n= 
6), and 22F straight (n=7), with internal diameters (IDs) of 7.2, 6.6, and 5.9 mm, 
respectively. They concluded that neither blood velocity nor the shape or size of the aortic 
cannulae mattered with respect to the number of cerebral ME. 
 
 
Grega et al
172
 2001 analysed 461 patients in a non-randomized study operated by a single 
surgeon in two groups looking at neurological and neuropsychological outcomes 
comparing single vs double-clamp technique. They were able to detect a significant 
improvement in neurological injury, reduction in the incidence of stroke and duration of 
hospital stay in the single clamp technique patients.  
 
The study by Hammon and colleagues
173
 of 395 patients has also shown a significant 
difference in NP outcomes when using single-clamp technique, venting of left ventricle and 
screening of ascending aorta using transoesophageal and epiaortic scanning. 
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Tsang et al
174
 2003 in a prospective randomized study demonstrated a significant decrease 
in the relative risk of adverse cerebral outcome without compromising myocardial 
protection with the use of a single aortic cross-clamp technique. They recommended that 
the use of the aortic side clamp should be avoided to minimize the handling of the 
ascending aorta, which could be a significant risk factor for embolic strokes following 
CABG. 
 
Martens et al
175
 2004 in a prospective randomized study of 77patients undergoing CABG 
compared the amount of debries released using intra-aortic filtration during the automated 
proximal anastomosis device (GroupI,n=38) and conventional handsewn (Group II,n=39) 
technique and found that the number of particulate debris being released and captured on 
the intra-aortic filter was the same regardless of the technique used. The 
neuropsychological tests did not reveal significant differences between groups. In Group I, 
eight patients showed a decline of 20% or more on at least two tests (20.5%), compared to 
six patients in Group II (15.8%). 
3.5.3. Post-surgical factors 
 
Rewarming rate 
Grigore and co-workers
84
 in a prospective study involving 165 patients undergoing CABG 
showed that slower rewarming during CPB was associated with better cognitive 
performance at 6 weeks. 
 
Low cardiac out-put state 
As discussed in the previous chapter ‘‘global hypoperfusion’’ plays a role in cerebral 
dysfunction whether it occurs during or after surgery. Poor LV function or an episode of 
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left ventricular failure is thought to be associated with a poor neurological outcome post-
operatively
60
. 
 
Post-operative atrial fibrillation 
Stanley and co-workers
174
 from the Duke Heart Centre studied the role of post-operative 
atrial fibrillation to NP dysfunction. Out of 411 patients, 308 completed both pre and post-
operative cognitive testing, 69 patients (22%) had post-operative atrial fibrillation. Those 
who developed atrial fibrillation showed more cognitive decline 6 weeks after surgery than 
those who did not develop post-operative atrial fibrillation (P=0.036). 
 
3.6. Influence of atheroma load on cerebral microembolism 
 
 
The Neurologic Outcome Research Group (NORG) from the Duke Heart Centre evaluated 
the ascending, arch and descending aorta of 128 patients to determine the aortic atheroma 
burden. They were able to demonstrate a significant but weak relationship between TCD-
detected cerebral emboli and the atheromatous load in the ascending and aortic arch using 
TOE. Atheroma load was found to be greatest in the descending aorta and least in the 
ascending aorta. They concluded by showing that the embolic load was significantly 
associated with atheroma in the ascending aorta (p=0.013), while there was no association 
between emboli numbers and descending aorta findings
177
. 
 
Another study by Bar-Yosef et al
178
 compared the relationship between aortic 
atherosclerotic disease and neuropsychological outcome following CABG. They compared 
TCD findings with TOE along with pre and 6-week post-operative NP assessment in 162 
(81%) patients out of 201. They found no significant relationship between NP dysfunction 
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and atheroma load in the ascending, arch and descending aorta. They concluded by saying 
that the aetiology of NP dysfunction is likely to be multifactorial and that aortic atheroma 
may not be the primary cause. 
 
A limitation of both these studies is that they used TOE to evaluate ascending aortic 
atheroma. A study by Konstadt et al
124
 showed that EAU is more sensitive and more likely 
to detect a greater degree of atheroma than TOE in the mid-ascending aorta up to the 
proximal arch, since large sections of the ascending aorta are not visible on TOE due to 
interposition of the trachea and the left main bronchus.  
 
There was clearly a need for a study analysing the correlation between the atheroma load 
using EAU of the ascending aorta with the embolic cerebral load using TCD and this was 
incorporated in my study design. 
 
 
3.7. Is the number of ME related to NP outcome 
 
 
Although ME may not cause any immediate symptoms in patients, there is evidence to 
show that NP changes are noticed whenever a significant number of ME enter the cerebral 
circulation.  
Pugsley et al
179
 in 1994 studied the incidence of ME in the middle cerebral artery using 
TCD and NP outcome in a randomized controlled group involving 100 patients undergoing 
CPB surgery. Fifty patients having surgery using a 40μm arterial line filter had less ME 
counted than the non-filtered group. More patients from the non-filtered group had 
significant NP deficits at both 8 days and 8 weeks in the post-operative period. 
 
Musumeci et al
10 
in a randomized study involving 100 patients undergoing elective CABG 
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surgery compared CA vs ICCF techniques as two different myocardial protection 
techniques and found no correlation between the total number of ME and NP outcome. 
They did notice slight deterioration in the Luria Nebraska Neuropsychological Battery 
(LNNB) tests for motor, visual, reading, memory and intellectual testing at 1 week but this 
recovered in all patients at 6 months.  
 
Others such as Sylivris et al 
13 
investigated to
 
verify whether ME signals correlated
 
with 
early NP deficits and to identify, using
 
magnetic resonance imaging (MRI) scans, whether 
radiologic evidence
 
of cerebral infarction correlated with microembolic numbers
 
during the 
bypass period. This study involved only 41 patients of which only 32 had NP testing. The 
NP testing was performed early at 5 or 6 days post-surgery. A total of 28 patients had both 
intra-operative TCD monitoring
 
and pre-operative and post-operative MRI scanning. Of the 
28 patients, 5 had evidence of cerebral infarction on
 
MRI scanning and 23 had no evidence 
of stroke. TCD monitoring confirmed that most ME occurred during CPB. A significant
 
early NP deficit after CABG did correspond to the total microembolic load during the 
bypass (p=0.008). However, there was
 
a significantly higher ME load before surgical 
incision of
 
the ascending aorta in patients with cerebral infarction detected
 
by MRI 
scanning (p<0.0001) and not during the bypass period. This same relationship was
 
not 
present in patients who had NP deficits post-operatively. Despite this, an analysis
 
of the 
overall group showed that MES during bypass (rates and
 
total counts) were not 
significantly higher in the MRI stroke
 
group compared with the non-stroke group. Their 
study concluded by showing that microembolic load during bypass is associated with
 
early 
NP deficits. In contrast, patients who showed
 
evidence of strokes during bypass surgery 
had
 
a higher microembolic load during the pre-incision phase than
 
those without cerebral 
infarction. Differing mechanisms may
 
be responsible for these different outcomes.  
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Fearn et al
180
 studied 70 patients undergoing CABG with TCD to measure ME and middle 
cerebral artery blood velocity along with NP assessments which were conducted pre-
operatively and at 1 week, 2 months and 6 months post-operatively. They found a weak but 
significant (p<0.02) correlation between emboli and a reduction in “overall memory 
reaction time” at 1 week post-surgery. In 40 patients, they detected more than 200 emboli, 
mainly during aortic cross-clamping and release, on initiation of bypass and finally while 
defibrillating the heart. Their study was also the first to report differing cognitive effects 
from emboli and hypoperfusion.  
 
Some investigators have questioned whether there is a relationship between ME count and 
certain surgical interventions with regard to the NP outcome.  Jacobs et al
46 
in a small study 
involving 18 patients undergoing CABG examined the relationship between ME, NP and 
cerebral glucose metabolism. In addition, in 2 patients who also underwent valve 
replacements, the ME count was even higher. Overall, they found no correlation between 
the number of HITS, NP outcome or global cerebral glucose metabolism. The significance 
of this study is doubtful because of the small number of patients involved. 
 
Mullges et al
181
 in 2003 analysed 60 patients undergoing CABG randomized to either using 
a short or long aortic cannula in the ascending aorta. All patients had 1-2 days pre-
operative and serial post-operative NP assessment (7 tests) on days 3, 6 and 9. The 
examiners were blinded from knowing what type of aortic cannulation was used. Only 
32/60 patients had intra-operative TCD and NP assessment and 54/60 had 9
th
 post-
operative NP assessment. In the 32/60 patients, they were able to show a marked reduction 
in the number of ME in the short cannula group compared to the long cannula group 
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(median 174.5 vs 413.0; p=0.011). They did not find any influence on early post-operative 
NP outcome. 
 
More recently Stygall et al
182 
in a longitudinal study of cognitive function after CABG 
examined 107 participants using 11 tests, pre-operatively and at 6 days, 8 weeks and 5 
years after surgery. The overall NP change score declined at 6 days, showed some recovery 
at 8 weeks and declined again at 5 years. The number of ME recorded during surgery, post-
operative short-term cognitive change and degree of recovery at 8 weeks were identified as 
predictors of change in NP score to 5 years. The authors point out that the number of ME 
detected may simply reflect the extent of the patients’ cerebrovascular disease. Therefore, 
as an alternative theory to ME causing the decline, ME could be a feature of those who will 
decline anyway. 
 
Recent interest in off-pump surgery has led investigators to see whether there are any NP 
outcome differences between on and off-pump coronary bypass surgery. Diegeler et al
183 
conducted a randomized study in Leipzig involving 40 patients (20 in each group). They 
showed a significant difference in the ME count and post-op NP outcome on day 7 in the 
on-pump group, suggesting that cognitive dysfunction seems to have a strong correlation 
with ME generation due to CPB. A small study by Malheiros et al
184
, however, showed a 
significantly lower ME count in the off-pump group (p<0.0001) with a longer bypass 
duration in the on-pump group. Inspite of this difference, they were unable to detect any 
NP differences between the two groups. Clearly an adequately powered study of much 
larger size is needed in this area. 
 
In a randomized larger study involving n=281 patients (On=139, Off=142) by Van Dij et 
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al
185
 from Netherlands studied NP outcomes at 3 and 12-month intervals. Ten NP tests 
before and after surgery were assessed. Quality of life, stroke rate and all-cause mortality at 
3 and 12 months were secondary outcome measures. The overall standardized NP change 
score at 3 months was p=0.03 and 12 months p=0.09 showing no significant differences. 
No significant differences were noted in the secondary outcome measures either. The same 
author
186
 more recently at the 5-year follow-up confirmed that off-pump coronary surgery 
had no added benefit effect on 5-year cognitive or cardiac outcomes. This was also shown 
to be the same in a much recent randomized follow-up study by Stroobant et al
187
 at 3 to 5 
years after the CABG (n=74) surgery. They showed no significant difference in NP 
outcomes between on and off-pump CABG patients, indicating that the cardiopulmonary 
bypass may not be the main cause of late NP decline. This was also shown in a recent  
analysis of the Revascularization On versus Off Bypass (ROOBY) trial data of 1156 
patients, only 1 of 9 neuropsychological outcomes at 1year following surgery favoured the 
off bypass group
234
.  
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3.8.  Summary 
 
 
In summary, all the above studies suggest that there is more than one factor that is 
responsible for generating ME that can ultimately have an impact on the NP outcome. 
Although very few studies have found an association between the number of microemboli 
generated during surgery and neuropsychological outcomes, for two reasons. First the 
constitution and size of the microemboli are likely to be more closely related to 
neuropsychological outcomes than the absolute number of microemboli generated.Second, 
the functional impact of these microemboli might also depend upon the extent of pre-
existing vascular disease in the brain. 
 
With this in mind, in our next chapter we will investigate whether there is any relationship 
between microemboli (ME), comparing ICCF and CA as the two myocardial protection 
techniques and NP outcome. 
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 Chapter 4  
 
Role of myocardial protection techniques in the 
neuropsychological outcome during 
cardiopulmonary bypass  
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4. Role of myocardial protection techniques in neuropsychological outcome during 
cardiopulmonary bypass  
 
4.1. Introduction 
 
Since the development of coronary artery revascularisation, CA has been the widely used 
technique of myocardial protection since the mid 1970’s. CA has since been 
comprehensively studied using crystalloid or blood. But even so there are still a substantial 
number who prefer to use ICCF as it has been safely used in both low and high-risk 
patients
188
. Exponents of ICCF claim that the technique is simpler, allows the myocardium 
to be reperfused during the procedure and has the potential to result in shorter ischaemic 
and CPB times
189
.  
 
However, ICCF is associated with more handling and repeated clamping of the aorta. It has 
been argued that especially in the presence of atheromatous disease, this manipulation may 
cause plaque adhering to the aortic wall to break or rupture releasing debris (ME) into the 
systemic circulation, thereby causing a proportion of these ME to eventually find their way 
into the cerebral circulation, increasing the risk of neurological and NP outcome
109
.  
 
Until now there have been only a few studies comparing these two techniques and looking 
at them in terms of the NP outcomes.  In this chapter, we will review literature looking into 
the historical background for any difference with regard to NP outcomes comparing ICCF 
with CA as the two forms of myocardial protection during CABG surgery using CPB as it 
forms the primary objective of investigation in this thesis.  
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4.2. Cardioplegic arrest  
 
The principle of CA is to minimize cellular metabolism and maximize cellular energy 
preservation without causing myocardial injury while providing the surgeon with a still and 
bloodless field. In addition to variations in temperature and composition of cardioplegia, 
different perfusion strategies to maximize coronary distribution can be adopted. Simply 
arresting the heart reduces the myocardial oxygen demand by nearly 90%; by cooling the 
myocardium cold cardioplegia significantly reduces the remaining 10% myocardial oxygen 
demand. Warm and tepid blood cardioplegia, on the other hand is believed to preserve 
cellular enzymes system and limit the cellular swelling and limit myocardial oedema. 
Cardioplegia solutions are used to arrest the heart in diastole and provide metabolic support 
to the heart muscle after cross-clamping the ascending aorta. It can be infused as a 
crystalloid solution or mixed with blood. The ideal cardioplegic solution should permit 
immediate cardiac arrest. Cardioplegia solution may be infused continuously or 
intermittently. Continuous infusion is maintained at a constant rate during cross-clamp 
time, intermittent cardioplegia is infused every 20 minutes for a short period (2-3 minutes). 
These two techniques could be given separately or in combination. Routes of infusion 
could be via the ascending aorta (antegrade) or coronary sinus (retrograde). The major 
concern with the antegrade method is poor preservation of the myocardium distal to 
coronary occlusion or stenosis while with the retrograde method there are issues regarding 
adequate protection of the right side of the heart, in addition to involving the anti-
physiological method of delivering the cardioplegia via the coronary sinus. In 1994, 
Hayashida an1 co-workers
190
 used the antegrade combined with the retrograde technique, 
which showed a better distribution of cardioplegia into the myocardium.  
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4.2.1. History and background 
 
Melrose et al
191 
introduced cold hypertonic potassium citrate blood cardioplegia in 1955. 
Following reports of left ventricular damage it was not used in the United States for almost 
a quarter of a century. Investigation by Tyers et al
192
 showed that the problem faced by the 
Melrose solution was inappropriate concentration of its constituents, rather than 
inappropriate composition. Numerous different cardioplegic solutions and methods of 
myocardial protection have been advocated since this date. 
 
Prerequisites for clinical use of cardioplegia should include: 1) a solution that is shown to 
be safe; 2) assurance of even distribution to all areas; 3) periodic replenishment to 
counteract non-coronary collateral washout and; 4) strategies for delivering and 
maintaining cardioplegia that can be adaptive to various clinical conditions. 
 
 
4.2.2. Effect on the NP and myocardial outcomes 
 
Although cardioplegic arrest is thought to cause less cerebral and NP dysfunction since this 
technique involves less handling of the aorta, there is still controversy regarding this 
technique and its relationship to NP deficits. Martin et al
193
 analysed 1,001 patients who 
were randomized to have continuous warm retrograde cardioplegia and normothermic 
systemic perfusion during CABG or hypothermic cold antegrade cardioplegia and noticed a 
significantly higher incidence of neurological and peri-operative cardiovascular problems 
in the first group. 
 
Baker AJ
170
 and colleagues in Toronto, Canada, using 3 different CA techniques (cold 
antegrade, warm antegrade and warm retrograde) detected a significantly greater number of 
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ME in the warm retrograde group than the cold antegrade (p<0.01) and warm antegrade 
(p<0.001) groups. This suggests more chances of neurological events occurring because of 
it. Therefore, with more ME being generated as discussed in the previous chapter this may 
have an influence on the NP outcome
179
. 
 
4.3. Intermittent cross-clamp fibrillation 
 
 
ICCF is one of the earliest forms of myocardial protection techniques that is still being used 
in some centres today
194
.
 
Despite its decreased popularity, it is considered to be safe, fast, 
simple and a successful alternative technique of preserving the myocardium during CABG 
using CPB by Korbmacker et al
106
.
 
The heart is electrically fibrillated using topical 
electrodes prior to application of the aortic cross-clamp. This induces global ischaemia, 
followed by anoxic arrest and electrical silence on ECG. This technique depends on 
reducing myocardial oxygen demand by moderate systemic hypothermia (32-33°C), 
followed by simultaneous workload reduction by emptying the heart and inducing 
ischaemic preconditioning of the myocardium
104,195
. These short ischaemic periods, 15-20 
minutes can rapidly be reversed by coronary reperfusion on release of the aortic cross-
clamp. Following completion of the distal graft, the heart is defibrillated and the proximal 
anastomosis performed using a partial occlusive side-biting clamp. 
 
 
4.3.1. History and background 
 
Senning
196
 in 1952 was the first to introduce a quiet, perfused heart using ventricular 
fibrillation and thereby avoiding intentional ischaemia. Subsequently, in January 1968, 
W.Dudley Johnson
197,198
, from Milwaukee, USA, became the first to use intermittent 
ischaemic arrest as the form of myocardial protection technique in CABG.  He believed 
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that there were several advantages in using ICCF compared to CA while performing 
coronary revascularisation: 1) the ventricular regional wall contraction could be assessed 
immediately between grafting of coronary arteries using ECG, once the heart was 
reperfused and spontaneously beating. Using cardioplegia, this assessment could not be 
made as the heart is stopped for a longer period of time; 2) the longer period used for 
grafting in difficult cases was found to accentuate the benefits of the “ischaemic 
preconditioning” effect on the heart and; 3) cardioplegic solutions are rich in potassium and 
potentially may have damaging effects on the endothelium whereas with the ICCF 
technique once the coronaries are bypassed the segment distal to the blockage would get its 
blood supply in a more normal physiological form immediately once the aortic cross-clamp 
has been released.  
 
4.3.2. Effect on the NP and myocardial outcomes 
 
As ICCF involves repeated clamping of the ascending aorta during surgery, this technique 
could subsequently have a catastrophic outcome with regard to cerebral and NP 
functioning. However, Bonchek et al
196
 reported only 1.1% transient and 1.8% permanent 
cerebral events in a series of 3,000 patients operated on with repeated aortic cross-
clamping. Raco and co-workers
199
 in 2002 analysed prospective data on 800 consecutive 
patients undergoing elective (n=520) and non-elective (urgent=226, emergency n=54) 
CABG using ICCF by a single surgeon. NP disorders were seen mainly in the non-elective 
patients with a total stroke incidence of 1.1% and TIAs of 0.4 % for all comers. This study 
suggests that ICCF is a safe technique with both elective and non-elective patients in the 
hands of an experienced surgeon. 
 
Musumeci
10 
and co-workers in a randomized study showed that in patients with no pre-
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operative evidence of aortic or cerebrovascular problems, repetitive clamping of the aorta 
in ICCF was not associated with a higher rate of cerebrovascular events, while comparing 
the single-clamp technique using blood cardioplegia. Some studies have suggested that the 
presence of atheromatous lesions markedly increase the risks
196,200
. Even the single-clamp 
technique used in cardioplegia with severe diffuse atherosclerosis would not be safe as 
shown by Aranki and co-workers
168
.  
 
The following studies have shown their myocardial benefits. By using more sophisticated 
methods of myocardium specific enzymes or proteins (Creatine kinase and Troponin I or T) 
to evaluate myocardial protection. Flameng et al
201
 in a randomized clinical trial in 1984 
assessed ICCF vs St. Thomas’s Hospital crystalloid cardioplegia using Creatinine Kinase 
Isoenzyme MB (CKMB) assays and concluded that ICCF is as effective as cardioplegia in 
protecting the myocardium. Pepper JR
202
 and colleagues in 1982 randomized 50 patients 
comparing cold St. Thomas`s crystalloid cardioplegia with ICCF. Using CKMB, left 
ventricular biopsies and post-op 12-lead ECG, they concluded that there were no 
differences while cross-clamp time was longer in the cardioplegia group. Anderson et al
103
 
in 1994 compared creatine Kinase MB isoforms and troponin T assays in 40 patients. 
CKMB 2 was found to be significantly higher in blood cardioplegia (n=20) compared to 
ICCF (n=20). Although troponin T (TnT) was raised in the cardioplegia group the 
difference was not significant. The randomized study of Taggart
104
 in the 1994’s and the 
retrospective analysis of Bonchek et al
188
 on 3,000 first-time CABG patients using the non-
cardioplegic technique have also shown ICCF to be safe and favourable.  
 
Musumeci`s 1998
10 
randomized study of 91 patients undergoing first time elective CABG 
concluded that CKMB, TnT and TnI (Troponin I) increased in both groups. The peak levels 
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at 10 hours, 24 hours, and 96 hours post-operatively were higher in the blood cardioplegia 
group. This reached statistical significance at 10 hours with CKMB (p=0.021) and 10hours 
and 24hours with TnT (p=0.038 and p=0.027). Despite longer bypass and ischaemic time in 
the cardioplegia group it was not statistically significant.  
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4.4. Comparing the two techniques in terms of NP outcomes 
 
 
 
                  ICCF                                                                                 CA                                                        
 
 
                                                          Advantages 
 
            
              Ischaemic preconditioning                        Physiological protection of heart 
             Shorter CPB time                                       Less handling of aorta 
             Shorter ischaemic time 
 
 
                                                         Disadvantages 
                                             
 
           Multiple handling of aorta                                   Longer CPB time 
                                                                                         Longer Ischaemic time 
 
                                                           Microemboli 
                         
                                          Increased cerebral dysfunction 
 
 
87 
 
The above chart compares the potential advantages and disadvantages between the two 
myocardial protection techniques.  
 
With recent interest in ischaemic preconditionin, a review by Scarci et al suggests that 
intermittent cross clamp fibrillation may also have a preconditioning benefit on the 
myocardium when compared to cardioplegic arrest
203
. This has been seen in a laboratory 
based study on Wistar rats by Fujii
204
 et al 2005 where there were evidence of a positive 
benefit between ischaemic preconditioning and ICCF technique. Nevertheless, a larger 
randomized clinical trial is still warranted. 
 
Several randomized clinical trials (Musumeci 1998
10
, Taggart 1994
104 
and Anderson 
1994
103
) have shown cross-clamp fibrillation to provide equal or even better cardiac 
outcomes when compared to CA.  
 
The 1980’s study by Pepper202 and co-workers revealed no significant differences in their 
study group of patients with well-preserved left ventricular function, with regard to 
myocardial protection outcomes between the two techniques. These results were also 
confirmed by later studies conducted by Bonchek
196
 and co-workers. Casthely 
105 
and co-
workers using TOE also confirmed no difference in post-operative systolic and diastolic 
function between the two groups.  
 
Other investigators such as Liu et al
105
 1998, Anderson et al
104
 1994, Cohen et al 
206
 1997, 
Alhan et al
200
 1996 and Gerola et al
207
 1993 have also clearly and repeatedly demonstrated 
in prospective randomized trials that the technique of ICCF is equivalent to both crystalloid 
and blood cardioplegia in terms of clinical outcome and biochemical markers of 
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myocardial injury. 
 
Korbmacher et al
106
 2004 in a recent review article compared a meta-analysis of published 
data taken from international centres using ICCF technique. They suggested that with 
regard to neurological outcomes, despite repetitive clamping of the aorta especially in 
patients with no previous evidence of pre-operative aortic or cerebrovascular disease, there 
was no evidence of increased cerebrovascular events similar to Musumeci et al`s 
prospective randomized trial of single-clamp technique using cardioplegia vs ICCF
5 
technique. This was also confirmed in another large retrospective study involving 2,000 
primary cases showing no significant difference between cold blood cardioplegia and ICCF 
with regard to cerebrovascular outcome
105
. While some studies suggest using caution and 
other myocardial protection when there is evidence of severe aortic atherosclerosis
200,205
.  
 
 
Currently there is only one study by Musumeci et al 1998
10
 comparing single-clamp 
cardioplegia against ICCF, examining the impact of repetitive aortic handling during CPB 
on the generation of ME and its relationship on neurocognitive outcome. They detected no 
statistical difference in the number of ME and neurocognitive deficit between the two 
myocardial protection techniques. However they did notice a difference in the pattern of 
ME release. ME occurred mainly during surgical manipulation during total and partial 
clamping of the aorta in the ICCF, while a continuous low-grade production of ME with a 
larger shower occurring when the aortic cross-clamp was removed was noticed in the 
single-clamp cardioplegia technique.  
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4.5.  Discussion  
 
 
All the evidence shown by several studies discussed in this chapter ranging from invasive 
(blood cardiac enzyme/protein markers, muscle biopsies) to non-invasive (post-op ECG, 
TOE) outcomes or end-point to suggest that ICCF is safe or even equal to CA technique in 
providing adequate myocardial protection in order to safeguard the overall function of the 
heart. Despite several comparative studies between the two techniques there is still only 
one randomized study in the literature by Musumeci et al looking into NP outcomes. 
 
Since all the above studies have suggested that ICCF is a safe myocardial protection 
technique to the heart, this randomized study was set up to find out the impact this 
alternative myocardial protection technique of ICCF might have with regard to NP 
outcomes when compared with the traditional CA technique because of its repetitive 
handling of the ascending aorta. 
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 Chapter 5  
 
Rationale for new study, methods and materials 
91 
 
5. Rationale for new study, methods and materials 
 
5.0. Introduction 
 
So far only one study by Musumeci and co-workers
10
 1998 have compared both myocardial 
and cerebral protection in a group of patients randomized to either single aortic cross-clamp 
technique n=43 (CA) or ICCF n=48. They detected no significant differences between the 
two groups on either number of intra-operative ME or post-operative NP performance. 
However, biochemical analysis did suggest that the ICCF technique afforded a more 
effective form of myocardial protection. Nevertheless, there are various methodological 
flaws within this study.  
 
This study was considerably underpowered as there were only 70 participants available for 
the final follow-up at 6 months to detect a significant difference between the two groups: In 
NP performance too the body temperature and flow rate during CPB differed in each group. 
Those receiving cardioplegia were cooled to 28C with a flow rate of 1.6 l/m2 per min 
while the intermittent cross-clamp patients were allowed to drift to 34C and flow 
maintained at 2.4 l/m
2.
per min. This could be potentially problematic, as hypothermia has 
been employed as a means of cardiac and cerebral protection throughout cardiac surgery 
history.  In addition, this study excluded patients with aortic disease and this may have 
reduced the impact of repeated cross-clamping in ICCF and resultant ME production, 
thereby producing a confounded result. 
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5.1. Study overview 
 
 
This chapter describes in detail the objectives, methodologies and results of a single-centre 
double blinded randomized clinical study undertaken by the author in collaboration with 
the Departments of Cardiothoracic Surgery, Anaesthesia, Neurology and Psychiatry at the 
Heart and Middlesex Hospitals, London, between February 2002 and December 2004. 
 
5.2. Descriptive Title 
 
A randomized clinical study to examine the effects of ICCF and cardioplegia with regard to 
the NP outcome during CABG surgery along with detection of ME generation using TCD 
and screening of ascending aorta for atheroma using DP,TOE and EAU during the 
procedure. 
 
5.3. Hypothesis 
 
It is proposed that the use of ICCF, through manipulation of the aorta is thought to be 
associated with increased microembolisation (ME). A higher burden of ME is thought to be 
associated with a worsening NP outcome; Therefore ICCF was hypothesised to have a 
poorer NP outcome than CA. 
5.4. Study objectives 
 
The primary objective of this study is aimed at comparing the occurrence of intra-operative 
ME and post-operative change in NP performance in patients undergoing CABG surgery 
using either ICCF or CA as a method of myocardial protection. 
The secondary objective is to compare intra-operative screening techniques of the 
ascending aorta using DP, TOE and EAU in the detection of atheroma to (1) compare the 
proportion of patients identified as having atheroma by these 3 screening techniques, and 
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(2) examine whether the 3 techniques identified the same patients as having aortic disease. 
 
5.5. Ethical approval 
 
The study was conducted in accordance with the provisions of the Declaration of Helsinki 
(amended 1989) and with the approval of the University College London (UCL) Hospitals 
Ethical Review Committee of Human Research.  
 
5.6.Sample size planning 
 
The sample size power calculation based on Z change score was founded from a previous 
study conducted by Arrowsmith et al at the institution of the present investigation based on 
the number of patients needed to detect a significant difference in neuropsychological deficit, 
which was the primary outcome measure of the trial. The incidence of deficit was estimated to 
be 20%9. The sample size required was 74 per group that is a total sample of 148 calculated 
to give adequate power (a 90% chance) to detect a 20% reduction in neuropsychological 
deficits at the 5% level. It was estimated that a 20-25% loss to follow-up was possible 
therefore it was calculated 200 participants were required to result in an adequately-
powered study.It was assumed that there would be equal size and equal variance for the 
control and treatment groups, using the formula below. 
Sample per group = 2*[Z (1-α) + Z (1-β)] ² / Δ ² 
Δ ² represents the standardized difference (i.e. the treatment divided by its standard 
deviation) 
 
 
5.7. Study population 
 
Patients who were on the elective waiting list from home and in-patients’ list for urgent 
CABG surgery were invited to take part in the study in the Department of Cardiothoracic 
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Surgery at the Middlesex/ Heart and University College Hospitals NHS Trust. 
 
5.8. Recruitment and consent of patients 
 
 Patients fitting the criteria were invited to participate. In accordance with ethics committee 
guidance, fully informed consent was obtained from all patients. The study was explained 
verbally to patients who were then given a written information sheet to read (see Appendix 
8.1). Patients were requested to sign a consent form if they agree to participate (the consent 
form was part of the Patient Information sheet / Informed consent form, see Appendix 8.1).  
 
A brief medical history and clinical examination along with a record of current medication 
were noted. Each patient was then enrolled into the study and identified by a unique patient 
identification number starting from ‘001’. 
 
5.9.   Inclusion criteria 
 
1. All patients over the age of 18 years and willing to participate. 
2. Case referral-elective and urgent CABG. 
3. First-time CABG or Re-do CABG. 
4. Patients fluent in English. 
5. Good visual and auditory acuity. 
6. Patients over the age of 80 years. Although these patients are at most risk of NP injury, 
they also have the highest co-morbidity and mortality, which may make them less likely to 
attend follow-up.  
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5.10. Exclusion criteria 
 
Patients were excluded from participating in the study if any of the following exclusion 
criteria was met. 
1. Existing or prior cerebrovascular disease and previous psychiatric illness. 
 
2. Unable to understand English. 
 
3. Unable to write or use the keyboard due to physical disability. 
 
4. Evidence of intra-cardiac thrombus. 
 
5.11. Randomization 
 
Two hundred and twenty envelopes containing 110 ICCF and 110 cardioplegia group were 
given to the perfusion department. On the day of the operation, the chief perfusionist in the 
presence of his assistant and the author would open the randomization envelopes (patients 
were blinded for treatment group assignment, all the investigators were subsequently 
blinded during analysis of all data). The operating surgeon would then be informed 
regarding the type of myocardial protection technique to be used after setting up the 
appropriate bypass circuit. When a patient had to be removed from the study because of 
failure to adhere to the protocol their allocated envelope was not re-used (e.g. surgery done 
off-pump) and these envelopes were marked as cancelled.  
 
 
5.12. Theatre protocol  
 
A standardized protocol developed from previous NP studies assessing outcomes post-
cardiac surgery involving anaesthesia, surgical technique, cardiopulmonary bypass, control 
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of blood pressure, mean perfusion pressure and control of pH was followed. 
 
5.13. Anaesthesia 
 
Using a standardised anaesthetic technique  as used  in most cardiac patients an hour prior 
to surgery, patients were given premedications consisting of 10-20mg Temazepam or 
Diazepam 5-10mg as per the anaesthetist’s preference. Oxygen as a supplement was given 
via a facemask at a rate of 4 l/minute starting from the time the premedication was 
commenced until induction of anaesthesia. Following conventional central venous and 
arterial line insertion, intervenous induction was commenced using fentanyl 5-10mcg/kg , 
propofol 0.5- 10mg/kg , or etomidate 0.05-0.1mg/kg and pancuronium 0.1mg/kg. 
Intubation was then carried with a number 7.0 or 8.0-cuffed endotracheal tube and 
ventilated with isoflurane (0-2%) in oxygen and air. 
 
The patient was intubated with a cuffed endotracheal tube and the lungs mechanically 
ventilated. Antimicrobial prophylaxis was then administrated. This usually consisted of 
Flucoxacillin and gentamycin or erythromycin in patients who where allergic to penicillin. 
 
A transcranial Doppler probe was than placed over the right zygomatic arch after urinary 
catheterisation and placement of a nasopharyngeal continuous temperature probe. 
Following this a transoesophageal echo probe was inserted into the oesophagus and the 
patient was subsequently transferred into the operating theatre. 
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5.14. Cardiopulmonary bypass (CPB) 
 
CPB was established between single right atrial and ascending aortic cannulae, non-
pulsatile flow was used throughout the bypass period using a roller pump. The 
cardiopulmonary circuit consisted of a hollow fibre membrane oxygenator (Quantum HF-
6700 BardLtd) and arterial filtration line (33m, Bard Ltd Prim-VuTM, Bard Ltd). The 
bypass circuit was primed with 1.6 litres of Hartmann’s solution heparinised with 5000 IU 
of sodium heparin. Full anticoagulation was achieved prior to aortic cannulation with 300 
IU/Kg heparin. Further doses of heparin were given throughout CPB and activated clotting 
time (ACT) was maintained greater than 400 seconds. The flow was maintained at 2.4 
l/min/m 2, reduced to 75% when full core cooling to 32-34C was achieved. Mean arterial 
pressure was maintained as close to 50mmHg as possible while on bypass. Using 
appropriate vaso-active drugs either constrictors (phenylephrine) or dilators (phentolamine) 
were administrated to achieve this.While on CPB patient was maintained on propofol 
infusion 1-2mg/kg along with actrapid 0-5units/h (adjusted to control blood sugar). Acid-
base regulation during CPB was carried out using the alpha-Stat protocol. At the end of 
CPB the anticoagulant effect of heparin was reversed with protamine sulphate to correct the 
ACT to pre-CPB levels. 
 
 
5.15. Myocardial protection technique 
 
Patients were randomized on the day of surgery to either ICCF or cold blood cardioplegia 
as the technique of myocardial protection. Depending on the randomization, patients in the 
ICCF group had their distal anastomosis constructed during brief periods (10-15 minutes) 
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of aortic cross clamping and ventricular fibrillation. Once each distal anastomosis was 
completed the aortic cross-clamp was released. If the heart failed to revert spontaneously 
into sinus rhythm then it was cardioverted using 10-20 joules using the internal paddles. 
The proximal anastomosis was finally completed using a partial side-biting clamp. This 
sequence was repeated as per the number of grafts needed by individual patient 
requirements.  
 
In the cardioplegia group, myocardial protection was achieved using 1 litre of antegrade 
cold blood cardioplegia (based on St.Thomas`s Hospital 1 solution). Further doses were 
infused at a rate of 150 to 200ml/minute at every 30-minute intervals. Once all the distal 
anastomoses were performed the cross-clamp was removed, the proximal anastomosis was 
then completed using a single side-biting clamp. All the vein grafts, irrespective of which 
myocardial protection technique was used, were carefully de-aired using a 25G needle. 
 
5.16. Intra-operative monitoring 
 
The author recorded the entire standard monitoring of mean arterial pressure, systolic and 
diastolic blood pressure (BP), and nasopharyngeal temperature, atheroma screening 
findings from DP, TOE and EAU and TCD recordings during various stages of the surgical 
procedure himself. (Appendix 8.3) In addition to transcranial Doppler monitoring there 
were specific intra-operative variables that have a potential influence on ME generation 
and NP outcomes were also recorded.  
 
They included: 
1. Clinical presence of aortic atheroma or calcification -- chest X-ray. 
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2. Intra-operative screening for atheroma in the ascending aorta -- DP, TOE and EAU. 
3. Minimum temperature on CPB. 
4. Maximum temperature reached following rewarming. 
5. Duration to rewarm to 37C. 
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5.17. Neuropsychological Test Protocol 
 
5.17.1. NP assessment test (pre and post-operative tests) 
 
All patients underwent neuropsychological testing by a single experienced psychologist on 
two occasions (i) preoperative assessment (twenty four to forty eight hours before surgery) 
and (ii) six to eight weeks after surgery. The patients were brought from their wards to the 
same room where tests were carried out under relaxed conditions. 
 
The New Adult Reading Test [NART] (Nelson and O’Connell 1978194) was undertaken pre-
operatively to obtain an estimate of premorbid IQ. 
 
 The battery of 9 NP tests chosen to cover a range of domains as detailed below had been 
developed at UCLH and included the core battery as recommended by the consensus 
meeting in 1995
195
. The tests selected are widely used in literature on CABG and have been 
shown to be sensitive to change following cardiac surgery (Pugsley et al
179
 1994) well- 
normalised and can be performed in the limited time available without disruption of clinical 
procedures.  
 
Where available, parallel forms were administered to limit the effects of learning between 
assessments. The battery consisted of: 
 
5.17.1.1. The Rey Auditory Verbal Learning Test [R-AVLT] (Rey 1964
210
) 
 
This widely used test involves free recall following the repeated verbal presentation of a 
15-word list. The same list is repeated 5 times with free recall after each presentation. This 
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sequence is followed by a presentation of a second (distractor) list followed by free recall. 
Immediately following this, the participants are required to recall as many words as they 
can from the first list without a further presentation (delayed recall). The total number 
correctly recalled over the first 5 trials (verbal learning) and the change between trials 5 
and 7 (delayed recall) were recorded. 
 
5.17.1.2.  Non-Verbal Recognition Memory Test [NVRM] (Pugsley et al 
1994
179
) 
 
This is a computerized timed recognition memory test in which 1 checker-board design is 
presented on a computer screen for 10 seconds and followed by 3 designs. The task is to 
identify which of the three designs is the same as the previous one as quickly as possible. 
The task consists of 20 presentations, with the total response time being recorded. 
 
5.17.1.3.        Trail making A [TMTA] 
 
This and the following test originally formed part of the Army Individual Test Battery
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(1944) and assess motor speed and attentions. Test A involves the participant in drawing 
lines, as quickly as possible through consecutively numbered circles. Time to completion 
was recorded. 
 
5.17.1.4.         Trail making B [TMTB] 
 
This is a parallel task to TMTA but more difficult, as it involves alternating between 
ascending numbers and letters. This test measures not only motor speed and attention but 
also mental flexibility. 
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5.17.1.5.       Letter Cancellation Test [LCT] (Talland and Schwab 1964
212
) 
This paper and pencil task consists of cancelling a random target letter from rows of letters. 
Performance was scored on time to completion. 
 
5.17.1.6.       Symbol Digital Replacement Test [SDRT] (Pugley et al 1994
179
) 
This is a computer driven task adapted from the paper and pencil version devised by Smith 
(1968, 1973). This requires the participant to pair 45 pre-coded digits with symbols. The 
score was time to completion. 
 
5.17.1.7.      Choice Reaction Time Test [CRT] (Pugsley et al 1994
179
) 
This is a computerized task in which participants are required to discriminate and respond 
as quickly as possible to two letters (A&B) which are displayed randomly on a computer 
screen. Mean response time was recorded. 
 
 
5.17.1.8.     Grooved Pegboard Test – Dominant [GPD] and Non-dominant 
[DPND]. Matthews and Klove 1964
213
) 
 
This timed test of manual dexterity and complex fine-motor co-ordination discriminates 
differences in right and left hemispheric performance. It consists of a small board 
containing a 5 x 5 set of slotted holes angled in different directions. Each peg has a ridge 
along one side requiring it to be rotated into position for correct insertion. The score was 
time to completion. 
 
5.17.1.9      Mood State 
 
In order to examine the impact of anxiety and depression on NP performance, it has 
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become increasingly common for mood state to be assessed at each time of testing. 
 
Depressed Mood: Center for Epidemiologic Studies Depression Scale [CES-D) 
(Radloff 1977
214
). This is a 20-item self-report measure for use in the general population 
studies to assess the presence and severity of depressive symtomatology. 
 
Anxiety: Spielberger State and Trait Anxiety Inventory [STAI] (Spielberger et al 1983
215
). 
This questionnaire consists of 20 items for measuring trait anxiety and 20 items for 
measuring state anxiety. The trait measure (administered pre-operatively only) provides an 
index of personality based anxiety level whereas the state anxiety level provides a measure 
of anxiety in the current situation. 
 
All tests were performed during the week pre-operatively (usually on the day preceding 
surgery) and then 6-8 weeks post-surgery. The pre-operative test was usually done the 
afternoon prior to surgery and the post-operative test on the day that the patient returned to 
the routine surgical follow-up clinic. 
 
5.17.2. Transcranial Doppler  
 
The author using a TCD (Nicolet EME Pioneer 4040, Uberlingen, Germany) monitored the 
microembolic events. The right middle cerebral artery (MCA) was isonated using a 2MHz 
pulsed wave transducer secured by a headband positioned on the right side of the skull just 
above the zygomatic arch between the lateral aspect of the eye and ear. The author did this 
prior to the skin incision since electrical (radio frequency) interference occurred during 
isonation from electrocautery. All measurements were made ‘off-line’ using international 
consensus criteria
160
 and a second observer reviewed 10% of the tapes to assess inter-rater 
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reliability. 
 
 
Microemboli were counted throughout from cannulation to 15 minutes post-decannulation. 
Nine surgical events were noted: 
Cannulation 
Time of going on CPB 
Cross-clamp on 
Top-end anastomosis, side-biting clamp on 
Top-end anastomosis, side-biting clamp off 
Cross-clamp off 
Coming off CPB 
Decannulation 
15 minutes post decannulation 
In line with other researchers (Stroobant et al
15
) the number of ME detected within one 
minute was considered to be associated with that event
11,12,99
. 
 
               Transcranial Doppler tracing of right middle cerebral artery 
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The Doppler loudspeaker was turned off during intra-operative monitoring so that the 
surgeon was blinded to the number and timing of the ME. Continuous transcranial 
monitoring was recorded from the start of the skin incision until 15 minutes after aortic 
decannulation. Video (VGA) signals from the TC4040 were converted to PAL format using 
an interface unit (Mediator, Video Logic, UK) and recorded in real time, with 
corresponding stereo audio signals on standard VHS videotape (AG6200, Panasonic, 
Matsushia Electric Co. Ltd. Japan). 
 
A second observer Ms. Jan Stygall who was blinded to patient details and treatment group, 
reviewed 10% of the tapes to check inter-rater reliability. 
 
5.17.3. Ascending aorta screening 
 
As it was not a standard practice to routinely use TOE and EAU technique in assessing the 
ascending aorta during cardiac surgery at the Heart & UCL hospital. Following verbal and 
written consent as part of a general screeing protocol to this study the ascending aorta 
(which was divided into three segments as proximal, middle and distal) was screened for 
atheroma using three techniques: DP, TOE and EAU during the pre-bypass intra-operative 
period only to detect atheroma, grade their severity and to aid during the surgical 
manipulation of the ascending aorta for the whole group rather then individually (ICCF or 
CA). 
 
 
106 
 
 
 
5.17.3.1. Digital palpation  
 
Once the pericardium was opened and prior to the harvest of the internal mammary artery, 
the surgeon digitally palpated the ascending aorta circumferentially from the innominate 
artery to the aortic annulus. The surgeon immediately described his findings, which were 
then recorded by the author. Simultaneously, the investigators (SS or AS) assessed the 
ascending aorta for atheroma with TOE using an ATL HDI 3000 machine with an MPT7-4 
TOE probe (4-7MHz).  
 
 
 
 Atheroma was graded as follows: 
Grade score: 
Grade 0 -- Normal, no thickening felt 
Grade 1 -- Abnormal, thickening felt 
(Cannulation and handling of aorta was avoided in those abnormal sites depending upon 
TOE and EAU findings.) 
 
5.17.3.2. Transoesophageal echocardiography  
 
Using an ATL HDI 3000 TOE machine with an MPT7-4 probe (4-7MHz), all patients were 
assessed by the author and a second investigator Dr. Andrew Smith, Consultant Cardiac 
Anaesthetist in the theatre prior to CPB and immediately post-CPB in the theatre. The 
author paid particular attention looking at the following findings: 
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Assessment of the ascending and thoracic aorta  
The overall left ventricular regional wall motion abnormalities 
 
The ascending and thoracic aorta were graded and scored by author as follows: 
 
TOE-1 Grade score:  (Distal to left subclavian-thoracic aorta) 
Grade 0 -- Normal, less than 1mm 
Grade 1 -- Mild atheroma, 1 to 2mm 
Grade 2 -- Moderate atheroma, 2 to 3 mm 
Grade 3-Severe atheroma, more than 3 mm, or mobile atheroma 
  
 
TOE-2 Grade score:  (Proximal ascending aorta) 
Grade 0-Normal, less than 1mm 
Grade 1-Mild atheroma, 1 to 2 mm 
Grade 2-Moderate atheroma, 2 to 3mm 
Grade 3 -- Severe atheroma, more than 3mm or mobile atheroma 
 
Left ventricular regional wall motion abnormality was assessed pre-bypass and post-
bypass. They were scored as per the national echo board grading protocol. (Appendix 8.3) 
Due to difficulties in imaging portions of the ascending aorta with TOE, only the proximal 
portion of the ascending aorta near the annulus was screened. 
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5.17.3.3. Epiaortic ultrasound  
 
Following the DP and TOE assessment, EAU was then used by the same surgeon performing 
the DP assessment to examine the ascending aorta for atheroma using a surface ultrasound 
P7-4 phased array probe (4-7MHz) with an ATL HDI 3000 machine (GE Healthcare, Bucks., 
UK). The probe was placed inside a sterile plastic sheath containing 20 to 50ml of sterile 
crystalloid solution. This acts as an interface to improve imaging of the anterior surface of the 
ascending aorta by eliminating air pockets. Attention was given to ensure that the sterile 
saline was free of any air bubbles. Approximately half to one centimetre of solution was left 
between the probe tip and the aortic surface.  
 
The ascending aorta was scanned in its proximal (aortic annulus upto right pulmonary artery), 
middle (portion directly in front of the right pulmonary artery) and distal (from the right 
pulmonary artery upwards) segments from the aortic annulus to the base of the innominate 
artery.  
The three aortic segments were scanned and atheroma graded as per a modified grading score 
devised by the author. 
 
Grading of aortic atheroma: 
Grade 0 -- Normal less than 1mm 
Grade 1 -- Mild atheroma between 1 to 2mm 
Grade 2 -- Moderate atheroma between 2 to 3mm 
Grade 3 -- Severe atheroma more than 3mm or mobile atheroma 
 
In total, 6 different surgeons were involved in the DP and EAU assessment. In each case, the 
surgeon performed the DP assessment and gave his findings before performing the EAU 
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assessment. The EAU assessment findings were recorded before making the surgeon aware 
of the TOE findings. To aid offline analysis, the EAU assessment was performed in the same 
manner for each case.  
 
Once the aorta was assessed, the surgeon following discussion with the author would modify 
any surgical cannulation or handling of aorta accordingly, thereby minimizing any chance of 
plaque disruption so as to reduce embolic events. 
 
These ultrasonography findings were recorded on to a VHS tape for further assessment by the 
author and 10% of the tapes that were randomly picked by computer by a national board echo 
certified Consultant Anaesthetist Dr. Andrew Smith. 
 
5.18. Demographic and other pre-operative data 
 
Age, sex, race, body mass index, grades of angina and dyspnoea, history of myocardial 
infarction, hypertension, diabetes mellitus, hypercholestremia, peripheral vascular disease 
and smoking, elective or urgent referral, number of coronary vessel disease, left main stem 
disease, left ventricular ejection fraction, Parsonnet score (initially used and later changed 
over to Euroscore), Euro Score and pre-operative medication were all noted. (Appendix 8.3) 
 
5.19. Intra-operative data 
 
Operation time, intra-operative systolic and mean arterial pressure, time on CPB, cross-clamp 
time, number of grafts, type of conduits used -- long saphenous vein, internal mammary or 
radial artery -- screening of ascending aorta for atheroma, timings of aortic cannulation, 
initiation of CPB, application of cross-clamp, total cross-clamp time, removal of cross-clamp, 
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application of top-end side biting clamp for proximal anastomosis, removal of side-biting 
clamp, cessation of CPB, total CPB time aortic decannulation, minimum and maximum 
temperature and time taken to rewarm from minimum temperature to 37ºC were all recorded. 
(Appendix 8.3) 
 
5.20. Post-operative data 
 
Once the patients were extubated and stable they were then assessed for any neurological and 
NP deficit. All relevant clinical findings were then documented. (Appendix 8.3) 
 
5.21. Analysis of results Neuropsychological, Microemboli 
 
Statistical analysis was performed using the Statistical Package for the Social Sciences 
Software (SPSS version 12.0. 1 for Windows). Univariate analyses were conducted using chi-
squared analysis or Fisher’s exact test where appropriate. To investigate group differences 
independent t-tests were performed on normally distributed continuous data and the Mann-
Whitney test on non-normally distributed data, to correct for any ties in ranking the ‘Z’ value 
was reported instead of the ‘U’. Due to the number of comparisons made and to avoid the 
likelihood of making a Type 1 error a significance value of  p = 0.01 was set.  
 
As a primary endpoint early studies investigating neuropsychological decline following 
CABG have rated the participants as either having or not having a deficit (reflecting both 
potential preserved learning ability and potential deterioration on the tests). This binary 
classification is insensitive and has the disadvantage of being unable to take into account any 
improvements in performance as they consider only deterioration. Therefore, to make optimal 
use of the neuropsychological data each patient’s pre- and post-operative scores were 
compared to create a change score. Each patient’s test score were converted into a standard 
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score using the standard deviation (SD) of the pre-operative group performance of all patients 
in the study.  Z score was calculated as z = (X2-X1)/ SD1), where X1 is the pre-operative 
score, X2 is the post-operative score and SD1 is the standard deviation of the pre-operative 
group scores.  This technique of analysis has been adopted in a number of studies on 
cognitive change in cardiac surgery
14,185
.  
 
In both methods of analysis, where improved performance on any test was reflected by a 
lower score, as in timed tests, the direction of the score was reversed so that all improvements 
gave rise to a positive score and deterioration to a negative score. A global Z change score 
was obtained by summing the change score of the individual tests. When a participant, 
because of cognitive difficulties, was unable to complete a task at follow-up a score of two 
standard deviations below the mean of the whole group for that test was recorded. 
 
In addition two secondary endpoints were calculated; firstly, from the mean and the SD of an 
individual test for the group of patients as a whole, a patient will be considered to show 
significant deterioration in the test if the score at an assessment falls 1 SD below the pre-
operative value. A patient was judged to show an overall neuropsychological deficit if a 
deterioration in 2 or more of the 10 neuropsycological tests were observed, reflecting the 
patient’s performance which is not influenced by the intrinsic ability to perform the test. Also 
secondly a similar assessment to that described above will be conducted except that 
significant deterioration will be defined as a 20% fall from the pre-operative value. 
 
Comparison of the proportion of patients with deficit in the test and control groups was 
performed using the 2 test. Comparison of the performance of the groups on any one test was 
determined using the Mann Whitney U test.  
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Difference in microemboli count between groups were analysed using the Mann Whitney and 
2   tests. 
Each patient will act as their own control and scored against their own pre-operative 
performance, thereby removing patient variation in the ability to perform the tests. 
 
5.22 Discharge from hospital 
 
Patients were usually discharged on either day 6 or 7 following surgery, depending on their 
individual needs either to their homes or to their nearest hospitals for convalescence. 
Details regarding timing of the patients’ discharge from hospital along with their relevant 
clinical findings were entered into their clinical data sheets (Appendix 8.3). 
 
5.23 Follow-up 
All cardiac patients were routinely followed up in the outpatients’ clinic 6 to 8 weeks from 
the time of their discharge. They were assessed clinically with an ECG and chest X-ray 
(Appendix 8.3). 
 
5.24 Patient withdrawal 
All patients recruited to the study were made aware of their right to withdraw from the study 
at any time without affecting their treatment or care.  
 
 
5.25 Data collection, storage and analysis 
All data collected in this study by the author were stored in a hard filing cabinet according to 
their unique study identification serial number, thereby protecting the patient’s identity 
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according to the patient’s data protection requirements. 
 
The research fellow (J. Stygall) entered all the data for subsequent analysis, which was 
carried out by Mrs. Jan Stygall and the author jointly. A second investigator  
(Jan Stygall) reviewed 10% of the tapes to assess the inter-observer reliability. 
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CONSORT  Flow Diagram: Figure 1 
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Excluded (n=5   ) 
   Could not complete NP tests (n=2 ) 
   Declined before surgery (n=3 ) 
     Converted to Off-pump=2 
     Converted to PTCA=1 
Analysed pre & post-op NP tests (n=95/101)  
 
Analysed ME count using TCD (n=82/83) 
 One  case, 3,601 ME detected hence  
excluded from analysis marked as an outlier 
Did not complete Follow up ICCF (n=6/101) 
Reasons:- 
Died-0 
CVA-1 
Medically unfit to attend-0 
Refused-3 
Moved Abroad-1 
Moved hospital-1 
 
 
 Received NP pre & post tests (n= 95/101 ) 
    Missing data (n=6) 
 
♦ Received TCD for ME count 
   (n= 83/101) 
   Missing data (n=18 did not receive TCD) 
 
Did not complete Follow up CA (n=12/94) 
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Died-3 
CVA-3 
Medically unable to attend-4 
Refused-0 
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Moved hospital-2 
 
 Received NP pre & post tests (n= 82/94 ) 
   Missing data (n=12) 
 
♦  Received  TCD for ME count 
    (n= 83/94) 
   Missing data (n=11 did not receive TCD) 
 
 
Analysed pre & post-op NP test (n= 82/94)  
 
Analysed ME count using TCD (n=83/83) 
 Excluded from analysis  (n= 0 ) 
 
Allocation 
Analysis 
Follow-Up 
Randomized (n=195) 
ICCF (n=101) & CA (n=94) 
 
 
Enrollment 
ASCENDING AORTA SCREENING FOR ATHEROMA using DP, TOE, & EAU 
([n =154 out of 200 patients recruited) Taken from the whole group undergoing 
CABG, irrespective of categorization to either ICCF or CA group 
NoTCD n=29  
Failure to isonate a 
trace 
In 19 patients aortic 
cannulation technique modified 
to avoid atheroma during aortic 
manipulation  
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6.  Results  
 
6.1. Recruitment 
 
Two hundred and twenty patients were approached and 200 agreed (n=20 declined) to 
participitate in the investigation between February 2002 and December 2004. Of the 
200 patients recruited to the study, 5 patients (2.5%) were excluded (shown on Table 
6.1) while of the 195 participants 177 (90.76%) completed both pre and post-
operative NP assessments (ICCF n=95, CA n=82). 
 
6.2.  Removal from study before or during surgery 
 
Out of 200 patients, 3 were excluded before surgery and 2 after randomization during 
surgery due to 2 being unable to complete NP tests, 2 scheduled for off-pump surgery 
and 1 for percutaneous transluminal coronary angioplasty (PTCA). 
Table 6.1 Summary of reasons for removal from study after recruitment 
 
Therefore, 195 patients were randomized, completed pre-operative NP assessment 
and successfully completed theatre protocol.   
 
 
 
Reason for removal No. of patients 
Unable to complete NP tests 2 
Converted to off-pump surgery 2 
Converted to PTCA 1 
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6.3.  Outcome after surgery 
 
Out of 195 patients 90.76% (n=177) returned for repeat NP assessment. The reasons 
why 18 patients failed to return are summarized in Table 6.2. 
 
Table 6.2 Summary of reasons for not returning for NP assessment follow up. 
Reason for not returning for NP follow-up No. of patients 
Completed 177 
Death 3 
CVA 4 
Medically unfit to return for testing (No CVA) 4 
Refused to return for testing 3 
Moved abroad 1 
Moved hospital 3 
Total 195 
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Table 6.3 Clinical outcomes and attendance at follow-up between groups. 
Final outcome ICCF CA 
Completed 95 82 
Died 0 3 
CVA 1 3 
Medically unable to attend 0 4 
Refused 3 0 
Abroad 1 0 
Moved hospital 1 2 
Total 101 94 
 
 
ICCF=Intermittent cross-clamp fibrillation, CA= Cardioplegic arrest, 
CVA=Cerebrovascular disease 
There were no statistical differences found between the two groups using 2   tests.  
 
Of the 3 deaths in the CA group one was due to respiratory arrest post extubation 
while 2 were due to multi-organ failure. There was 1 CVA in the ICCF and 3 in the 
CA groups, of which atheroma was detected in the ICCF as moderate and moderate 
and severe in 2 CA patients while no probe was available for use in the remaining 
patient in the CA group. 
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6.4. Pre-operative data 
 
6.4.1. Patient characteristics 
 
Of the 195 participants 181 were Caucasian, 3 Black, 7 Asian and 4 belonged to another 
race. 
 
Table 6.4 Characteristics of participants (n=195).  
Variables  ICCF (101) CA (94) p Value 
Male 89.1 % 90.4 % 
Age (yrs) 65.5 (7.7) 66.9 (8.2)                0.222 
Education (yrs) 10.09 (1.7) 9.69 (1.9)                0.221 
Elective 60.4 % 64.9 %                    0.556 
BMI (kg/m
2
) 28.7 (3.7) 28.3 (4.3)                0.472 
Euro Score 4.46 (2.4) 4.78 (2.3)                0.611 
Ejection Fraction  
Good 
Moderate 
 Poor 
 
74.3 % 
17.8 % 
7.9 % 
 
 
76.6 % 
18.0 %                    NS 
5.3 % 
Diabetes 14.9 % 16.0 % 0.415 
 
Figures are expressed in means with standard deviations in parenthesis. Yrs=years. BMI= 
Body Mass Index. 
 
There were no significant differences in the demographic and clinical characteristics 
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between the two groups. The average age of the patients and predominance of male patients 
are in line with the UK population of patients undergoing coronary artery bypass grafting 
surgery (UK National Adult Cardiac Surgical Database Report 2000-2001). In the initial 
phase of the study Parsonnet risk stratification score was used and subsequently it was 
changed over to Euroscore. 
 
6.4.2. Pre-operative cardiovascular history 
Table 6.5 The   pre-operative cardiovascular history of the participants (n=195). 
History ICCF (101) CA (94) p Value 
Elective group 61       (60.39%) 61       (64.89%) 0.517 
Stable angina 96       (95.04%) 93       (98.93%) 0.422 
Unstable angina 11       (10.89%) 3         (3.19%) 0.072 
MI 50       (58.41%) 47        (50%) 0.238 
Dyspnoea 60       (59.40%) 57       (60.63%) 0.401 
PTCA 7         (6.93%) 11        (11.70%) 0.250 
Hypertensive 78       (77.22%) 76       (80.85%) 0.535 
LV aneurysm 1         (0.99%) 0 0.333 
Peripheral vascular 
disease 
6         (5.94%) 7         (7.44%) 0.674 
Diabetes 15       (14.85%) 15       (15.95%) 0.415 
Hypercholestremia 68       (67.32%) 65       (69.14%) 0.785 
Smoker  
Ex/Still 
79       (78.21%) 
58(57.42%) 
21(20.79%) 
66       (70.21%) 
54(57.44%) 
12(12.76%) 
0.215 
Using χ2 there were no significant differences between the groups in pre-operative 
cardiovascular history 
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6.4.3. Pre-operative medications 
 
The pre-operative medication regime may imitate the severity of disease and may 
potentially affect outcome variables such as microemboli production or the 
inflammatory response. Table 6.6 details the percentage of patients in the two groups 
using medications to control ischaemic heart disease. 
  
Table 6.6 Number (%) of participants on pre-operative medication (n=195). 
 
Medication ICCF (n=101) CA (n=94) p Value  
Beta Blockers 72 (71.3%) 63 (67.0%) 0.519 
Nitrates 56 (55.4%) 57 (60.6%) 0.467 
Ace inhibitors 51 (50.5%) 43 (45.7%) 0.507 
Statins 81 (80.2%) 81 (86.2%) 0.266 
Warfarin/Clopedogril* 20 (19.8%) 19 (20.2%) 0.604 
Aspirin* 93 (92.1%) 88 (93.6%) 0.678 
Anti-arrhythmia 3 (3.0%) 1(1.1%) 0.622 
 
*Anti- platelets and anti-coagulants were discontinued one week prior to surgery. A 
small percentage of patients were on Warfarin for AF and Clopidogril post-stent 
insertion. 
 
Using χ2 there were no significant differences between the groups in pre-operative 
medication. 
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6.4.4. Pre-operative Neuropsychological tests  
 
Table  6.7 Means and standard deviations (sd) of the raw pre-operative NP tests 
and mood state scores (n= 177). 
NP TEST  ICCF (n=95) Cardioplegia (n=82) 
Trail Making Test-A 
a
  39.75        (12.6) 39.87            (14.9) 
Trail Making Test-B 
a 
85.42        (33.7) 95.28            (39.7) 
Letter Cancellation Test 
a 
93.50        (22.7) 98.23            (25.8) 
Grooved Pegboard test D 
a 
85.75        (20.9) 86.71            (20.8) 
Grooved Pegboard test Non-
Dominant 
a 
98.52        (26.4) 96.07            (23.9) 
Symbol Digital 
Replacement Test 
a 
178.8        (49.5) 190.24          (56.3) 
Non-Verbal memory 
Recognition test 
b 
81.53        (33.95) 84.50            (24.4) 
Rey Auditory Verbal 
Learning Test-T 
c 
43.52        (9.5) 42.78            (10.1) 
Rey Auditory Verbal 
Learning Test –Delayed d 
-1.93         (2.1) -2.15             (1.6) 
Choice Reaction Test 
b 
.57            (.16) .57                (.12) 
New Adult Reading Test 
c 
33.22        (11.1) 33.06            (11.7) 
Speilberger-State Trait 
Anxiety Inventory-S 
35.97        (11.8) 37.63            (11.40) 
Center for Epidemiological 
Studies-Depression scale 
10.57        (8.1) 11.39            (8.3) 
a
 Time to completion (seconds). 
b 
Mean response time (seconds). 
c
 Number correct.   
  
d 
Difference score. 
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All patients received baseline pre-operative NP testing. Table 6.7 details these results. 
There was no significant difference using the t test in pre-operative NP scores 
between the two groups. The two groups were, therefore, well matched in terms of 
pre-operative NP performance. 
 
6.5. Intra-operative data 
 
6.5.1. Intra-operative clinical data 
 
Table 6.8 Intra-operative data (n=165/166) 
Variables ICCF(n=82) CA (n=83) p  Value 
Operation time 188.4        (37.3) 194.7            (29.5) 0.194 
CPB time 73.4          (21.3) 72.9              (17.7) 0.891 
Crossclamp time 31.3          (10.9) 41.1              (10.7) <0. 001 
No. Grafts 2.91 2.85 0.586 
Internal mammary artery grafts 86 86 0.108 
Total ME* 228.1        (352.5) 229.41          (283.2) 0.642 
Post-op AF 17 16 0.890 
. * Outlier excluded, one ICCF patient had 3,601 ME 
Time in minutes. Standard deviations in brackets. 
There were statistically significant differences noticed in the total cross-clamp time 
between the two groups with longer cross-clamp time in the cardioplegia group. But 
the overall speed of surgery when compared to other published studies does suggest 
that this is due to surgeons using intermittent cross-clamp fibrillation technique for 
myocardial protection. 
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No statistically significant differences were detected between the groups as shown in 
Table 6.8 with regard to operation time, total cardiopulmonary bypass time, number 
of grafts, total microemboli generation, and post operative atrial fibrillation.  
 
6.5.2. Intra-operative mean arterial pressure  
 
Table 6.9 Comparisons of means and standard deviations (sd) of the mean 
arterial pressure (MAP) between groups during pre and post bypass (n=195) 
MAP ICCF (n=101) CA (n=94) t-value p Value 
Pre-induction  77.66    (10.68) 78.63      (12.39) -0.582 0.561 
Post-induction
 
72.84    (13.49) 75.25      (14.50) -1.195 0.234 
Pre-sternotomy
 
72.83    (14.85) 76.52      (16.86) -1.617 0.107 
Post-sternotomy
 
  8.56    (17.00) 85.51      (18.53) -0.760 0.448 
Pre-CPB
 
65.01    (10.45) 65.05      (10.50) -0.029 0.977 
Post-CPB
 
67.81    (9.40) 67.76      (10.16) 0.037 0.971 
Post-skin closure
 
68.67    (8.94)   68.89      (9.40) -0.167 0.867 
 
Figures are expressed in means with standard deviations in parenthesis 
No significant differences noted in the mean arterial pressure between the two groups. 
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6.5.3. Intra-operative temperature 
 
Table 6.10 Comparisons of means and standard deviations (sd) of the temperature 
between groups during pre and post-bypass periods (n=195) 
 
Temperature ICCF (n=101) CA (n=94) t-value p Value 
Pre-induction  36.46     (.31) 36.45         (.34) 0.170 0.865 
Post-induction
 
36.06     (.41) 36.04         (.38) 0.341 0.734 
Pre-sternotomy
 
35.70     (.42) 35.58         (.48) 1.857 0.065 
Post-sternotomy
 
35.54     (.455) 35.35         (.53) 2.726 0.007 
Pre-CPB
 
35.09     (.58) 34.88         (.54) 2.627 0.009 
Post-CPB
 
36.92     (.47) 36.86         (.65) 0.704 0.482 
Post-skin closure
 
35.82     (.51) 35.82         (.53) 0.000 1.000 
Min temp during 
operation
 
31.95     (.60) 31.78         (.34) 2.481 0.014 
Max temp during 
operation
 
37.33     (.22) 37.39         (.25) -1.974 0.050 
Rewarming time
 
17.07     (4.0) 18.22         (4.43) -1.883 0.061 
 
Figures are expressed in means with standard deviations in parenthesis. 
 
The Post sternotomy and pre bypass temperature in the cardioplegia group was found to be 
significantly cooler when compared with the intermittent cross clamp fibrillation group. 
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6.5.4. Intra-operative screening of the ascending aorta 
 
6.5.4.1. Patient characteristics and co-morbidities 
 
The characteristics of the 154/195 patients (78.97%, n=154/195) who underwent 
assessment of their ascending aorta using DP, TOE and EAU are shown in Table 6.11.  
Table 6.11 Patient characteristics and co-morbidities 
Variable           Value 
Age           66 ± 8.03 
Male           142 (92%) 
Female                         12 (8%) 
Ejection fraction  
Good           118 (77%) 
Moderate                                                          26 (17%) 
Poor           10 (6%) 
Insulin dependent diabetes mellitus                       13 (8.4%) 
Non-insulin dependent diabetes mellitus                  7 (4.5%) 
Diet-controlled diabetes mellitus                              3 (1.9%) 
Hypercholestremia             112 (72.7%) 
Hypertension          124 (80.5%) 
Pre-operative statin use          130 (84.4%) 
Peripheral vascular disease            11 (7.1%) 
Body mass index                                                   28.30 ± 3.75 
EuroSCORE             5.21 ± 6.3 
Values are number of patients (percentage) or mean ± S 
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6.5.4.2. Digital palpation (DP) comparing Epiaortic ultrasonography (EAU) 
 
Table 6.12 Comparing detection of atheroma by DP and EAU  
 DP 
 
 
EAU 
 
Atheroma Present Absent Total 
Present 17                    64                  81 
Absent 3                      70                           73 
Total 20 134 154 
 
 
Sensitivity and specificity of DP in detecting aortic atheroma against EAU (gold standard) 
Sensitivity [Σ +ves] = Σ + ves ÷ Σ + ves + Σ + false × % = 20.98% 
                                                    [17 ÷ 17 + 64 × 100 = 20.98 %]  
                                                        
Specificity [Σ -ves]= Σ -ves ÷ Σ - ves + Σ + false × % = 95.89 % 
                                                    [70÷70+3×100=95.89%] 
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6.5.4.3. Transoesophageal echocardiography (TOE) comparing Epiaortic 
ultrasonography (EAU) 
 
Table 6.13 Comparing detection of atheroma by TOE and EAU  
                                                     TOE 
 
 
EAU 
 
Atheroma Present Absent Total 
Present 25 56 81 
Absent 6 67 73 
Total 31 123 154 
 
Sensitivity & specificity of TOE in detecting aortic atheroma against EAU (gold standard) 
Sensitivity [Σ +ves] = Σ + ves ÷ Σ + ves + Σ + false × % = 30.86 % 
                                                    [25 ÷ 25 + 56 × 100 = 30.86 %]  
                                                        
Specificity [Σ -ves]= Σ -ves ÷ Σ - ves + Σ + false × % = 91.78 % 
                                                    [67÷67+6×100=91.78%] 
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6.5.4.4. Transoesophageal echocardiography (TOE) comparing epiaortic 
ultrasonography (EAU) of proximal ascending aorta 
 
Of the 47 patients identified as having atheroma in the proximal segment of the ascending 
aorta by EAU, 26 (55%) of these were not detected by TOE.  Of the 31 patients identified 
as having atheroma using TOE, 10 (32%) of these patients showed a normal proximal aorta 
with EAU (Table 6.14).    
 
Table 6.14 Comparing detection of atheroma by TOE and EAU proximal-epiaortic 
ultrasonography 
 
                                                     TOE 
 
EAU 
proximal 
Atheroma Present Absent Total 
Present 21 26 47 
Absent 10 97 107 
Total 31 123 154 
 
Sensitivity [Σ +ves] = Σ + ves ÷ Σ + ves + Σ + false × % = 44.68 % 
                                                    [21 ÷ 21 + 26 × 100 = 44.68 % ]  
                                                        
Specificity [Σ -ves]= Σ -ves ÷ Σ - ves + Σ + false × % = 90.65 % 
                                                    [97 ÷ 97 + 10 × 100 = 90.65 
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6.5.4.5. Comparing all Digital palpation, Transoesophageal 
echocardiography and Epiaortic ultrasonography (proximal, middle 
& distal ascending segment) 
 
Table 6.15  Comparing detection of atheroma by DP, TOE and EAU.  
 
 
Atheroma Present Absent 
DP 20 134 
TOE 31 123 
EAU 81 73 
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6.5.4.6. EAU detection of atheroma in the proximal, middle & distal 
ascending segment 
 
The extent of overlap between detection of atheroma at the mid and proximal sites of the 
ascending aorta by EAU indicated that in 24 (36%) of the 67 cases where atheroma was 
found in the mid-segment it was not detected in the proximal segment. In contrast, in 92% 
of cases (43/47) where atheroma was detected at the proximal segment it was also found in 
the mid-segment of the ascending aorta. A comparison between the proximal and distal 
sites showed 43% (23/53) instances of distal atheroma not detected proximally and 36% 
(17/47) cases of proximal atheroma not found to have atheroma distally (Table 6.16).    
 
Table 6.16 Presence or absence of atheroma in the proximal, middle & distal segment 
of the ascending aorta as detected by EAU. 
                                              EAU middle 
 
EAU 
proximal 
Atheroma Present Absent Total 
Present 43 4 47 
Absent 24 83 107 
Total 67 87 154 
 
                                              EAU distal 
 
EAU 
proximal 
Atheroma Present Absent Total 
Present 30 17 47 
Absent 23 84 107 
Total 53 101 154 
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6.5.4.7. Total atheroma detection by DP, TOE & EAU 
 
 
 
 
 
Figure 2. Total atheroma detected by DP n=20 
 
 
 
 
Figure 3. Total atheroma detected by TOE n=31 
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Figure 4. Total atheroma detected by EAU n=47,  
 
 
 
 
 
Figure 5. Grading of atheroma of three segments detected by EAU n=167 in 81 patients 
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6.5.4.8. Grade score of atheroma 
 
The proportions of mild, moderate and severe atheroma in each segment of the ascending 
aorta using EAU are summarized below in Table 6.17. Atheroma was most common in the 
mid-segment of the ascending aorta (67/154; 44%), followed by the distal (53/154; 34%); 
with the least atheroma detected in the proximal segment (47 /154, 31%).   
 
Table 6.17  
Frequency of mild, moderate and severe atheroma in the three aortic segments (proximal, 
middle & distal) as detected by EAU in the 81 patients: 
 
Grading and distribution of atheroma in the 3 segments of the 81 patients detected by EAU 
technique. 
 Proximal Middle Distal Total 
Mild 37 42 34 113 
Moderate 8 20 16 44 
Severe 2 5 3 10 
Total 47 67 53 167 
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6.5.4.8. Atheroma grading as detected by DP, TOE and EAU in the four 
patients with cerebrovascular accident (CVA) 
 
In 3 patients atheroma was scored as present using DP while in 2 of them TOE graded 
atheroma as mild while EAU graded proximal, mid and distal segment as moderate and 
severe. In the third patient, TOE and EAU graded atheroma as normal. In the fourth patient 
EAU detected mild atheroma in all the three segments while DP and TOE were normal. 
 
Table 6.18: 
 
Pt with CVA DP TOE EAU-proximal EAU-mid 
EAU-distal 
1 Present Mild Moderate Moderate Moderate 
2 Present Mild Severe Severe Severe 
3 Absent Normal Mild Mild Mild 
4 Present Normal Normal Normal Normal 
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            6.5.4.10 Intra-operative transcranial Doppler (TCD) data of microemboli (ME) 
 
One hundred and sixty-six patients (85.12%) out of 195 patients had complete intra-
operative TCD monitoring of the right middle cerebral artery along with video recording on 
to a VHS tape. Microembolic events were counted throughout from cannulation to 15 
minutes post-decannulation.  
 
Table 6.19 Medians and range of ME detected at different surgical time-points. 
Comparison by Mann-Whitney test (n=165/166). 
Surgical event ICCF (n=82) CA (n=83) Z  p Value 
Cannulation 2   (0 – 12) 2 (0 – 15) -0.483 0.629 
Icpb 7 (0 – 110) 8 ( 0 -71) -1.551 0.121 
x-clamp on 3 (0 – 75) 5 (0 – 83) -0.645 0.519 
x-clamp off 1 (0 – 68) 0 ( 0 - 21) -2.151 0.031 
PA on 2 ( 0 -60) 2 (0 – 125) -0.051 0.959 
PA off 3 (0 – 34) 4 (0 – 56) -1.141 0.254 
cCPB 0 (0 – 5) 0 (0 – 5) -0.005 0.996 
Decannulation 0 ( 0 – 6) 0 (0 – 8)  -1.721 0.085 
15 mins post 0 (0 – 6) 0 (0 – 19) -1.895 0.058 
Spontaneous 71 (6 – 1525) 68 ( 0 – 1,176) -0.443 0.658 
Total ME* 105 (9 – 1757) 110 ( 1 – 1,306) -0.579 0.563 
 
* Outlier excluded iCPB = initiation of CPB, x-clamp on = cross-clamp on, x-clamp off = cross-clamp off, 
PA on = proximal anastomosis on, PA off = proximal anastomosis off, cCPB = cessation of CPB, 15 mins 
post = during the 15 minutes post cannulation. 
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The total number of ME detected per participant from cannulation to 15 minutes post-
decannulation ranged from 1 to 1757 (mean=231.01, sd=318.9) and a median of 107 (inter-
rater reliability r=.91). In one participant, 3,601 ME were detected (ICCF group). 
Therefore, all the analyses involving ME were conducted both with and without this 
outlier. No differences between these analyses were found.  
 
There was no significant difference (Mann-Whitney Test) in total emboli count between 
the two groups or ME occurring at any of the different stages of the operation including 
periods of no manipulation. 
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6.6. Post-operative data 
 
6.6.1. Post-operative clinical data prior to discharge 
Table 6.20 Number (%) of participants with   post-operative complications prior 
to discharge (n=195). 
Complications ICCF (n=101) CA (n=94) p Value 
IABP 1            (0.99%) 2          (2.15%) 0.513 
Inotropes 21          (20.79%) 12        (12.76%) 0.135 
ECG-AF 11          (10.89%) 8          (8.69%) 0.568 
Post MI 1            (0.99%) 0 0.341 
Bleeding 4            (3.96%) 4          (4.39%) 0.880 
Cardiac arrest 2            (1.98%) 1          (1.09%) 0.623 
Low cardiac output 10          (9.90%) 13        (14.28%) 0.350 
CVA 1            (0.99%) 3          (2.15%) 0.513 
Psychosis  2            (1.98%) 4          (4.39) 0.337 
Multi-system 
failure 
1            (0.99%) 2          (2.19%) 0.500 
Respiratory failure 1            (0.99%) 2          (2.19%) 0.500 
Renal-filtration 1            (0.99%) 3          (3.29%) 0.264 
Operative death 0 1          (1.08%) 0.293 
Post-op death 
Days to discharge       
0 
7 
2          (2.1%) 
8 
0.134 
0.198 
Using χ2 there were no significant differences between the groups in post-operative 
complications prior to discharge 
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6.6.2. Out-patients follow-up data 
 
In the outpatients’ clinic 177 patients (90.76%) out of 195 were followed up while 18 
patients (9.2%) were missing as mentioned earlier (Table: 6.2). 
 
No significant differences were noted between groups with reference to recurrence of 
angina, shortness of breath, sternal, leg and forearm wound healing, readmission to 
hospital, drug usage (aspirin, ace-inhibitor, statins, warfarin, clopidogril, beta 
blockers). 
 
6.6.3. Post-operative NP data 
 
In total, 90.76% (n=177, ICCF n=95 & CA n=82) out of 195 participants underwent 
complete pre and post-operative NP testing.  
 
6.6.4.  Post-operative 6-8 week Mean Z change score 
 
Table 6.21 Comparisons (n=177) of  means and standard deviations (SD) of Z change 
score for all NP tests at 6 weeks post-surgery in the intermittent cross-clamp 
fibrillation (ICCF) and cardioplegia (CA) group. 
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Table 6.21 (n=177) 
 
Figures are expressed in means with standard deviations in parenthesis. a Time to 
completion (seconds). b Mean response time (seconds). c Number correct. d Difference 
score.* This score was calculated with Choice Reaction Time included. When analysed 
with this test excluded, the difference between the two groups remained non-significant 
(P=0.326). 
TEST  ICCF (n=95) CA (n=82) t-value p Value 
Trail Making Test-A 
a
  0.183      (0.94) 0.093        (0.79) 0.677 0.499 
Trail Making Test-B 
a 
-0.029     (0.71) 0.167        (0.72) -1.813 0.072 
Letter Cancellation Test 
a 
0.300      (0.82) 0.288        (0.75) 0.102 0.919 
Grooved Pegboard 
Dominant 
a 
0.535      (0.68) 0.554        (0.62) -0.185 0.854 
Grooved Pegboard Non-
Dominant 
a 
0.621      (0.64) 0.443        (0.56) 1.956 0.052 
Symbol Digital 
Replacement Test 
a 
-0.044     (0.68) 0.215        (0.67) -2.521 0.013 
Non-Verbal Recognition 
Memory Test 
b 
0.100      (0.68) 0.194        (0.64) -0.937 0.350 
Rey Auditory Verbal 
Learning Test-T 
c 
-0.128     (0.73) 0.080        (0.79) -1.815 0.071 
Rey Auditory Verbal 
Learning Test –Delayed d 
0.128      (1.3) 0.100        (1.4) 0.134 0.893 
Choice Reaction Test 
b 
0.025      (0.64) -0.076      (0.89) 0.870 0.386 
Total NP change* 1.69      (3.31) 2.06        (3.4) -0.720 0.473 
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           6.6.5 Comparison of characteristics of patients followed up and withdrawn 
 
The follow-up rate was 90.76 % for the 6-week repeat NP testing. The pre-operative 
and intra-operative findings were compared between patients who did and did not 
return for follow-up. The idea was to analyse all the patients who failed to return for 
whatever reason so that the 3 patients who died were included in the 18 patients 
withdrawn (Table 6.22). 
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Table 6.22 Peri-operative characteristics of patients followed up or withdrawn (n=195). 
Variable Returned (n=177) Withdrawn (n=18) p Value 
Age 65.85(7.720) 69.67(9.792) 0.053 
Sex              Male 
                  Female 
161 
16 
14 
4 
0.079 
Years of Education 9.92(2.010) 9.75(3.019) 0.793 
BMI 28.59(3.900) 27.64(4.977) 0.356 
Ejection fraction 
Good 
Moderate 
Poor 
 
133 
32 
12 
 
14 
3 
1 
 
0.966 
Euroscore Score 4.49(2.244) 6.06(2.980) 0.007 
Speilberger State 
(anxiety) 
36.77(11.792) 37.00(8.874) 0.346 
CESD (depression) 10.84(8.162) 13.25(8.648) 0.662 
    
 
The only significant difference was found in the Euroscore (p = .007) with those not 
completing having a significantly higher Euroscore (mean 6.06) than those completing 
(mean 4.49). 
6.6.5. Relationship of ME to NP outcome 
 
A total of 166 patients received intra-operative TCD and also completed NP follow-up at 6-
8 weeks.  
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6.7. Summary 
 
 
Figure 6: Summary of number of patients receiving the main tests 
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Chapter 7  
 
                                         Discussion of results   
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7. Discussion of results   
 
7.1. Introduction  
 
The study of neuropsychological (NP) outcomes following coronary artery bypass grafting 
(CABG) surgery has been challenging for a number of reasons. Since it was performed, 
there have been ongoing improvements in surgical and anaesthetic techniques, as well as 
changes in the patient population undergoing CABG. The surgical population not only is 
older, but has greater prevalence of associated disease, particularly diseases that are known 
risk factors for cerebrovascular disease. As a consequence, the investigations and NP 
outcomes after CABG surgery in many ways has been a study of a moving target. All these 
may or may not add to mortality, days in hospital and the use of rehabilitation facilities
223
. 
 
This study presented in this thesis evolved from one small study comparing the post-
operative neuropsychological (NP) performance and microemboli (ME) generation in 
patients undergoing intermittent cross-clamp fibrillation(ICCF) or cardioplegic arrest (CA) 
during CABG finding no significant differences between the two groups
10
. However with 
only 70 participants being followed up at 6 months the study was underpowered.It 
excluded patients with aortic disease which may have reduced the impact of repeated cross-
clamping.Also; flow rates and body temperatures differed between the groups, leaving the 
possibility that other risk factors could have confounded the results. 
 
Therefore this randomized study set out to compare the generation of microemboli and 
post-operative neuropsychological performance outcomes as the primary objective while 
comparing the detection of atheroma in the ascending aorta using three intra-operative 
screening techniques Digital palpation (DP), Transoesophageal echocardiography (TOE) 
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and Epiaortic ultrasonography (EAU) in a large group undergoing either intermittent cross-
clamp fibrillation (ICCF) or cardioplegic arrest (CA) during coronary artery bypass 
grafting (CABG) surgery. 
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7.2.Microemboli generation comparing the two myocardial protection techniques 
 
As previously discussed, the relationship between ME generation and NP outcome is 
complex. Although ME are considered to be an important mechanism in the aetiology of 
NP changes post-CABG, it is well accepted that this is a multifactorial problem and the 
changes are not attributable to ME alone.The generation of ME during manipulation of the 
aorta has been often cited as a cause for concern when considering ICCF as a technique for 
myocardial protection. 
 
Most investigators have continued to use TCD as the current method for detecting intra-
operative ME despite its limitations. Only 90 % of the people have an adequate window in 
the temporal bone through which the middle cerebral artery can be isonated.This 
anatomical and technical problems (as explained in the results chapter, the video recorder 
failed to record a trace for 29 patients = 14.87%) with trace recording meant that not all 
(166/195 =85.12%) patients in the present study received TCD monitoring. The right 
cerebral artery is one of the six arteries supplying the circle of Willes leading to the 
question if one or both middle cerebral artery should be isonated.Some studies have shown 
that a combined count of both the middle cerebral artery recording is more accurate as it is 
closer to the total number of ME.However this is likely to be just a proportionate estimate 
unless all the six arteries are monitored. Moser et al 
162 
study suggests that it does not 
matter whether the unilateral or bilateral/ right or left middle cerebral artery is used for 
monitoring.Wijman et al 
157
 have shown that cerebral ME occurs frequently in the middle 
cerebral artery when compared to the anterior cerebral artery using TCD.Another limitation 
of the TCD is its inability to differentiate gaseous from particulate ME, let alone the many 
types of particulate microemboli have been addressed in the previous chapters. Future 
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study should have the potential to determine which factors carry pathogenic influence. 
 
 As with most TCD studies ME were found in all participants and the number of ME 
detected was comparable to Arrowsmith et al and Stroobant et al
14,15
 studies showing no 
difference between groups.  
 
There was, however, no correlation between NP changes scores and number of ME.In this 
study Spearman’s rho correlations were conducted between total ME and NP change 
scores, revealing no correlations either as a whole group (rho = 0.159) or separately by 
group (ICCF:rho = 0.063, p =0.581 versus CA: rho = 0.244, p =0.036). It is important, 
however, that a relationship between NP performance and ME is not always found given 
the limitations of microemboli detection as it is unsurprising to find no consensus in the 
literature.  Although some studies (Bonchek et al 2003
102
, Brown et al 2000
63
,  Stump et al 
1996
11
 and Barbut et al 1994
99
) have found a relationship, other investigators (Arrowsmith 
et al 1998
14
 and Stroobant et al 2005
15
 and) have not found any. One explanation for this 
may relate to the composition of the ME. It is probable that particulate matter may lead to a 
greater impact on the brain in comparison to gaseous ME because the gaseous bubble may 
dissolve as the partial pressure changes while particulates will form a complex block across 
the capillaries. The composition of ME can be either particulate (atheroma, fat, platelet 
aggregates, foreign material from the equipment used etc) or air. The final location where 
the ME lodges in the brain cannot be determined and the area may not be covered by the 
cognitive tests that are currently used. 
 
The use of ICCF remains to be popular among certain units in the UK because of recent 
evidence that it may produce an ischaemic pre-conditioning effect on the heart
217
 . Most 
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studies in literature have used cardioplegic myocardial protection techniques, which tend to 
be associated with a longer bypass and ischaemic times. The relative short bypass times 
with intermittent cross-clamp techniques would be expected to decrease ME count on the 
assumption that the relationship is linear. Although repeated cross-clamping of the 
ascending aorta can theoretically increase ME production there is no consistent evidence 
that intermittent cross-clamp fibrillation produces more ME than cardioplegic techniques as 
shown by Musumeci
10
 et al in 1998. In fact it is possible that since ICCF tends to be 
associated with shorter cross-clamp and bypass times, the total ME generated could be less 
than with cardioplegia. Musumeci study, however, failed to show any significant 
differences in the number of peri-operative ME generated or post-operative NP outcome. 
However, with only 70 participants completing the follow-up assessment at 6 months, the 
study was underpowered to detect any significant changes in NP performance. In addition 
the exclusion criteria in this study of patients with aortic disease may have reduced the 
impact of repeated cross clamping. Finally, both flow rates and body temperature differed 
in the two groups leaving the possibility that factors other than differences in myocardial 
protection could have perplexed the results.   
 
There are some important differences between the present study described in this thesis 
compared to Musumeci and collegues 
10
 study mentioned above: the participants in our 
study were older and none were excluded if they had aortic disease; also, body temperature 
and flow rate during CPB did not differ between the two groups.Both groups were well 
matched in terms of pre-operative characteristics, but ischaemic time was shorter in the 
intermittent cross-clamp fibrillation group with a significantly longer ischaemic time in the 
cardioplegia group (p < 0.001).No differences in operation time,CPB time,total number of 
grafts,or internal mammary artery grafts.There were no difference between groups in the 
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number of patients developing post-operative atrial fibrillation (Table 6.8). Epiaortic 
ultrasonography and transoesophageal echocardiography resulted in the site of aortic 
cannulation being changed in 18 patients to avoid atheroma. In all the right cerebral artery 
was isonated and its recording obtained in 166 patients (n =166/195, 85.12%). 
 
Shorter cross-clamp times have frequently been found in patients undergoing intermittent 
cross-clamp fibrillation, compared to those receiving cardioplegia but this has not been 
noted in all studies
104-105,108
 . It has often been debated whether a shorter CPB time with 
intermittent cross-clamp fibrillation may be better for the brain when compared to 
cardioplegic arrest 
10,105
. No CPB time difference was found in this study, possibly because 
all surgeons were skilled in both techniques, resulting in short bypass times (mean <74 
minutes) in both groups. 
 
A number of studies have demonstrated that the occurrence of ME can be linked to various 
aspects of surgery. In particular they have been related to the onset of bypass, aortic 
cannulation and removal of clamps
11
 . Given the difference in the 2 procedures it is likely 
that the number of microemboli generated at each manoeuvre may vary between the 2 
groups. In this study even though a greater number of ME were detected in the ICCF group 
at the removal of cross-clamp, this difference was not significant. However, during all of 
the other 8 manipulations, the number of ME was higher (albeit not significantly) in the 
cardioplegia group. As with previous studies
11,15
 although showers of ME were detected at 
the time of the 9 surgical events, especially initiation of CPB and proximal anastomosis, 
the majority of ME occurred spontaneously.  In this study, the number of spontaneous ME 
constituted approximately 80% of the ME in each group, resulting in no difference being 
found between the groups in total ME. These findings differ from Musumeci et al
10
 who 
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found that patients undergoing ICCF produced more ME during surgical manipulation 
whereas with CA the majority of the emboli occurred spontaneously.  This difference may 
be due to methodological factors regarding ME detection and the criteria for considering 
the ME as related to a surgical event. We rated ME as being associated with a surgical 
event if they occurred within 1 minute of a manoeuvre, a definition used previously by 
other authors
11,12,99
; however, the time-frame used was not stated in the Musumeci et al 
paper
10
. It is of note that no differences were found between the 2 groups in the occurrence 
of ME at each surgical event, despite the increased manipulations of the aorta in ICCF. 
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7.3. Neuropsychological  outcome 
 
A substantial number of investigations have endeavoured to clarify the causes of post-
operative NP deficits, yet the cause and mechanisms of NP dysfunction remains 
unconfirmed. This study has established that there is no evidence for any difference in the 
generation of ME and the NP changes produced between ICCF and cardioplegia methods 
of myocardial protection at each surgical event, despite increased manipulation of aorta in 
the fibrillation group. Both the groups showed an overall improvement in NP performance 
post-operatively. 
 
This study confirms similar findings as shown by Musumeci and colleagues
10
, where the 
Luria Nebraska Neuropsychological Battery of tests comparable to the Wechsler Adult 
Intelligence Test-Revised was used (WAIS-R). These tests were carefully chosen to be 
sensitive to detect change and thus compliant to repeated administration. One measure of 
cerebral damage is the inability to learn a task or strategy, which is the underlying basis of 
practice effects. The form of analysis used in this study takes into account any learning, or 
failure to learn post-operatively, and a general improvement would be expected. The NP 
tests were performed with an established and widely used battery and produced no 
significant differences between the groups in overall performance or any of the individual 
tests.  
 
As the overall neuropsychological change score was considered as the primary end-point of 
the study, the findings should be considered to suggest that using neuropsychological 
change, as an index of the potential impact of these two procedures on brain function, is 
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equivalent at least under the conditions and testing procedures performed here. 
 
  
It has been argued that mood prior to cardiac surgery, especially anxiety, may influence NP 
performance
10,226,232
.  However, the groups were well matched through random allocation 
on mood and more importantly no association between NP performance and anxiety and 
depression was seen. Therefore, the lack of differences seen in overall NP performance was 
not related to mood. Both groups showed an overall improvement in NP performance post-
operatively, learning which is what you would expect.   
 
 
Finally, most interestingly comparisons were made of patient characteristics, baseline NP 
performance and baseline mood state between those attending the follow-up NP assessment 
and those not attending. The only significant difference was found in the Euroscore 
(p=.007) with those not completing having a significantly higher Euroscore (mean 6.06) 
than those completing (mean 4.49).There were no significant preoperative differences 
between the groups in demographic characteristics, premorbid intelligence quotient, 
neuropsychological or mood status (Tables 6.4 and 6.7). There was no correlation between 
anxiety (r = 0.135, p = 0.122) or depression (r = 0.032, p = 0.717) and neuropsychological 
performance outcome. 
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7.4. Screening of the ascending aorta using three different techniques for atheroma  
 
As previously mentioned Kapetanakis et al
108
 in a risk-adjusted study of 7,272 patients 
undergoing CABG showed that the incidence of post-operative cerebral injury increases 
with aortic manipulation. Therefore, detection of atheroma in the ascending aorta prior to 
manipulation during CABG is considered to be important to reduce the overall incidence of 
cerebral injury and NP deficit
178,216
  . Various investigators have examined the usefulness 
of DP, TOE and EAU in the past
127,128,129
. Despite this, EAU is not routinely used in 
cardiac surgery. Davila-Roman
113
 and Royse
130
 have demonstrated the superiority of EAU 
over TOE and DP to detect atheroma in all age groups. 
 
This study compared the relationship between the findings of DP, TOE and EAU in the 
detection of atheroma in the ascending aorta.  A total of 154 patients had their ascending 
aorta screened using all the three screening techniques. Using DP, atheroma was detected 
in 20 patients (13 %), using TOE in 31 patients (20%) and using EAU in 81 patients (53%).   
 
Assuming that EAU is the ‘gold standard’, TOE and DP were compared with EAU to 
assess the relative sensitivity and specificity of each for atheroma detection. When DP was 
compared with EAU, 17 of the 20 cases identified by DP were positively identified by 
EAU (Table 6.12). Therefore, this shows that DP has a poor sensitivity for the detection of 
aortic atheroma with only 20% of the atheroma found using EAU being detected. This may 
be due to the fact that the finger can easily miss lesions within the lumen and is only suited 
to detecting the much larger, calcified lesions. Although the specificity of DP against EAU 
is relatively high, there were 3 false positives, which further demonstrate the relative lack 
of accuracy of DP compared to EAU. These findings were similar to 2 other previous 
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studies; Royse et al study of 70 patients, who found that DP was an insensitive method for 
detecting atheroma, as 50% of important atheroma detected by EAU was not found on 
DP
130
. Bolitin et al (n=105) also found DP to detect 55% (n=22/40) of atheroma found on 
EAU
128
. 
 
Comparing TOE with EAU, 25 of the 31 cases graded as positive for atheroma by TOE 
were positive for atheroma with EAU. In 6 cases, atheroma was detected with TOE but 
EAU detected no atheroma (Table 6.13). These 6 false positives may be due to artefacts 
generated in the near field of the plane of ultrasound. Furthermore, clear visualization of 
the distal ascending aorta may be difficult due to the trachea and left main bronchus lying 
between the oesophagus and aorta as highlighted in the earlier chapter
124
. Therefore, due to 
difficulties in visualizing the ascending aorta clearly beyond the proximal segment of the 
ascending aorta using TOE it could be argued that the most appropriate comparison of the 
capabilities of these two techniques in imaging atheroma should be to compare TOE 
detection with EAU detection in the proximal segment of the ascending aorta. Of the 47 
patients identified as having atheroma in the proximal segment of the ascending aorta by 
EAU, 26 (55%) of these were not detected by TOE.  Of the 31 patients identified as having 
atheroma-using TOE, 10 (32%) of these patients showed a normal proximal aorta with 
EAU (Table 6.14).  Since there were difficulties in visualising the mid and distal ascending 
aorta using TOE when comparing TOE with the EAU proximal findings. TOE detected 
only 45% (21/47) of the cases found to have atheroma in the proximal segment of the aorta 
compared to EAU. These findings suggest that even where it is purported to have the best 
imaging ability TOE does not detect as many cases with atheroma as EAU. The relative 
sensitivities of TOE and DP for detecting atheroma in the ascending aorta were low at 
30.86% and 20.98% in comparison to EAU (Tables 6.12 & 6.13). Despite these imaging 
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difficulties, TOE has been recommended as a screening technique and has been shown to 
improve outcomes in CABG
117,125
. 
 
The EAU findings were used to describe the distribution of atheroma in the ascending aorta 
(Table 6.15). Atheroma was most common in the mid-segment of the ascending aorta 
(67/154; 44%), followed by the distal (53/154; 34%); with the least atheroma detected in 
the proximal segment (47 /154, 31%).   
 
The extent of overlap between the detection of atheroma at the mid and proximal sites of 
the ascending aorta by EAU indicated that in 24 (36%) of the 67 cases where atheroma was 
found in the mid-segment, it was not detected in the proximal segment. In contrast, in 92% 
of cases (43/47) where atheroma was detected at the proximal segment it was also found in 
the mid-segment of the ascending aorta. A comparison between the proximal and distal 
sites showed 43% (23/53) instances of distal atheroma were not detected proximally and 
36% (17/47) cases of proximal atheroma were not found to have atheroma distally (Table 
6.16).   
  
Therefore, this study shows that when examined by EAU, the mid-segment of the 
ascending aorta yielded the greatest incidence of atheroma, followed by the distal and 
finally the proximal segment. These findings were similar to Sylivris
 
et al
122
 study 
involving 100 patients in whom EAU was found to be superior to both TOE and DP in all 
three segments, especially so in the mid and distal segment. These findings are important 
since aortic cannulation, application of cardioplegia line, cross clamping of aorta and 
application of side-clamp for top-end anastomosis is usually conducted in the middle and 
distal segment of the ascending aorta. It is only with an assessment of all segments of the 
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ascending aorta that atheroma will be detected. The ability to generalize to other segments 
of the ascending aorta, based on findings from the proximal segment of the ascending aorta 
in particular, is poor. This further strengthens the argument for imaging the ascending aorta 
using EAU instead of just using a TOE imaging modality. 
 
Since previous investigators have associated the presence of severe atheroma with higher 
incidence of cerebral injury
115,117,118
, grading and location of atheroma are important in 
predicting the overall clinical outcome.  Using EAU in this study atheroma detected in the 
proximal segment showed mild 72%, moderate 12% and severe 4%; middle segment 
showed mild 62%, moderate 29% and severe 7% and distal segment showed mild 64%, 
moderate 30% and severe 5% (Table 6.17). In this study, 4 patients had CVA. Using TOE 
and EAU, in 3 patients the atheroma was graded as mild, moderate and severe while the 
fourth was graded as normal (Table 6.18). Therefore, in summary in this study of elective 
patients undergoing CABG, the atheroma was detected in 53% by EAU. Furthermore, in 19 
(24%) of these patients, surgical technique was modified to avoid sites of atheroma during 
aortic manipulation. These findings suggest that currently the detection of atheroma by 
EAU should be considered as a routine procedure in CABG so that any neurological 
incidence could be minimized. 
 
We have used definitions of important atheroma that would result in including more 
lesions. And perhaps as expected, the EAU seems to be more sensitive to detecting these 
plaques. High frequency probes applied directly to the aorta would be expected to detect 
smaller lesions. 
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7.5.Summary 
 
 
This studies finding therefore suggest that there are no overall differences in microemboli 
generation between ICCF and CA the two common methods of myocardial protection, and 
that these techniques do not result in different degrees of neuropsychological outcome.  
 
7.6. Strengths and weaknesses of the study 
 
Before drawing some conclusions it is worth commenting on the strengths and weaknesses 
of the study and discussing how this should limit interpretation.  
 
 A prospective randomized trial is the most scientifically valid of various types of clinical 
study. However, such clinical trials have inherent limitations because however rigorous the 
attempts are to standardize procedure, there will be events and variables beyond the 
investigators’ control. For example, although we devised a standard protocol for screening 
the ascending aorta, it was not possible to screen all randomized trial patients using the 3 
screening techniques because of unavailability of echo probes as other patients by other 
clinicians were using them. There were limitations to the extent one can impose protocols 
on clinicians however willing they are to participate in trials. Randomization should deal 
with the uncontrollable variables if numbers are adequate and this has been the case in the 
present study. 
 
At present unfortunately, there is no one single gold-standard NP test battery for measuring 
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NP outcome and no universal scoring method exits as noted by a study reviewing  62 
clinical studies were less than half of the studies included the tests as recommended by the 
1995 consensus statement
227
.  All the NP tests used in this study have been widely used and 
are in agreement with the recommended consensus statement for assessing NP changes 
following cardiac surgery
83
. Although there are a number of approaches to assess NP 
changes following CPB surgery, in most cardiac surgical situations patients are under tight 
time constraints in receiving investigations and prepation for surgery. This often limits the 
time available for NP testing. This in reality limits the testing time to approximately one 
hour. During which time studies have to be limited, naturally with more number of tests 
used it might be possible to detect more deficits. 
 
In particular, the binary classification fails to account for the frequently observed 
improvements that occur with repiation on NP tests because it considers only deterioration 
in performance while the improvements observed in the tests are considered as an 
unwanted occurrence.  Therefore, this classification suffers from a number of issues 
regarding its sensitivity and the fact that it is conventionally defined and these 2 factors 
limit its ability
218,219
.
 
The alternative method is to use a continuous measure of 
performance. Here the standardized Z score used in this study has been widely utilized in 
other studies
193
.
 
In this study, both measures have been used even though it is documented 
that the binary classification system has severe limitations
14,185
.  
 
As shown by previous investigators even our study has failed to show any relationship 
between NP performance and ME events
10
. This is not suprising since until recently there 
has been no technique available to discriminate between gaseous and particulate ME. The 
final location in the brain of a microembolus cannot be determined and it may be lodged in 
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an area that cannot be covered by the cognitive tests that we currently use. 
 
 
 
 
There were some unavoidable limitations to this study. We recruited patients from 6 
different consultant surgeons and used more than 8 consultant anaesthetists to participated 
in a standard anaesthetic protocol that could be used during either ICCF or blood 
cardioplegia technique during myocardial protection. As with the anaesthetist the surgeons 
had an agreed protocol with regard to using the side-biting clamp during top-end 
anastomosis.Also there are limitations to the extent once can impose protocols on clinicians 
however willing they are to participate in trails.Choice of anaesthetic agents may have an 
influence on the NP outcome as shown in a randomised study by Schoen et al comparing 
sevoflurane vs propofol during cardiac surgery
224
.
 
 
 
There were further limitations in this study which relate to screening of the ascending aorta 
(a) the use of DP, TOE and EAU to screen the ascending aorta for atheroma and to aid in 
the modification of the surgical management in a randomised study could have possibly 
helped in altering the findings leading to no difference in the ME load, or NP outcome. It 
would have been useful to compare the patients’ atheroma load between ICCF and CA 
groups comparing the severeity of the atheroma grade along with their ME load and final 
NP deficit outcomes.This was not looked at as there were planning and issues relating to 
(b) the ‘blinding’ of the personnel involved in the atheroma assessment. The surgeons, 
while performing the DP assessment were blinded to the TOE assessment. When they 
performed the EAU assessment, although they were blinded to the TOE results, they were 
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aware of their previous DP assessment. To keep the DP assessor blinded from the EAU 
assessor involved increasing the ‘scrubbed’ personnel and was felt to be practically 
unfeasible in our institution. 
 
In addition some aspects of the study could be criticised.In an attempt to reduce 
confounding variables we did not recruit patients who had any previous or existing cerebral 
injury and patients with psychiatric illness.However,it could be argued that by attempting 
to reduce variables outside our control we may actually excluding the very patients who 
could potentially benefit from these myocardial protection techniques with regard to NP 
outcomes.Excluding these types of patients will have reduced further the expected 
incidence of deficit and will have reduced the statistical power of the study.The strict 
criteria may also mean that the present study is not representing the whole CABG surgery 
population and therefore may limit its abilty to generalise from its results. 
 
The aim of any randomized study is to have similar variables between groups. While 
analysing the intra-operative data the cross-clamp time was found to be significantly longer 
in the cardioplegia group in comparison to the ICCF technique (Table 6.8). There were also 
no statistical differences noticed between the detection and generation of ME between the 
ICCF and cardioplegia group during different surgical events (Table 6.8). It is, therefore, 
important to note the importance of a randomization study, since most studies especially 
screening and detecting microemboli have not been properly randomised with recent off-
pump techniques
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, epiaortic scanning and using minimal or no touch Y-grafting 
techniques
101
. Although it is impossible to reach an absolute conclusion from this type of 
analysis, the fact remains that this is a well powered single institutional study, involving 6 
surgeons competent in both cardiac techniques taking part in a randomized study involving 
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a single, stereotyped procedure allowing focus on specific procedural-related issues.  
 
 
 
7.7. Conclusion of the study 
 
The null hypotheses tested were:  
1) There will be no significant difference in the NP outcome when ICCF or cardioplegia 
are used as myocardial protection techniques. 
2) There will be no significant difference in the ME generated when ICCF or cardioplegia 
are used. 
 
This study has found the first null hypothesis to be true. No significant difference in NP 
outcome was found when the ICCF group was compared to the standard cardioplegia 
group. Any arguments relating to the preferred technique, therefore, should focus on the 
extent to which these techniques achieve the better form of myocardial protection with least 
NP deficit. 
 
Using both incidence of deficit and standardized Z change scores, this randomized 
controlled clinical trial of 195 patients has not found any conclusive evidence of an NP 
deficit using ICCF when compared to standard cardioplegia technique.  
 
Finally this study provides evidence to suggest that there is no evidence for any difference 
in the generation of microemboli and neuropsychological outcome differences between 
these two methods of myocardial protection techniques in an adequately powered and 
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randomized study with well balanced groups is reassuring to those who practise either 
technique.In particular, it denies concerns regarding intermittent cross-clamp fibrillation, 
and the strong views that some hold about this technique. 
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7.8. Suggestions for future studies 
 
As the ageing population of patients undergoing coronary surgery continue to increase 
along with other co-morbid factors, future studies would be necessary to address and 
determine the presence of atheromatous lesions in the ascending aorta. This may require a 
future rich with routine advanced  imaging techniques (CT/MRI
231
)
 
 prior to using intra-
operative epiaortic ultrasonography examination to better evaluate and reduce/prevent 
cerebral and NP sequelae of ME along with an improved NP testing 
225
.
 
 
 
Newer Transcranial Doppler techniques may be able to determine the relative pathogenicity 
of particulate, gaseous and lip ME generated. 
 
The low incidence of NP deficits in this study suggests that future studies will need to 
either have less strict inclusion criteria or have a greater number of participants requiring a 
multicentre investigation. There might also be a need to look and refine the existing NP 
tests by making them more sensitive and should include at the least the core battery as 
stated in the” Statement of Consensus” and must also should work towards a consensus on 
the definition of cognitive decline and the definition of control groups
226
 .  
 
 
Finally, given the similarity of effect by cardioplegia and ICCF techniques on generation of 
NP outcomes, and ME the contemplation of which form of myocardial protection is to be 
employed should possibly focus more on which method affords more protection to the 
heart. 
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